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Among the family of persistent organic pollutants, the most potent 
compound is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). One of the striking 
effects of TCDD exposure in animals is wasting syndrome: weight loss due 
to severely diminished food intake. Key mediator of the effects of TCDD 
is the aryl hydrocarbon receptor (AHR). Therefore, in this thesis various 
rodent models with different AHR structures or expression levels – and 
with different sensitivities to TCDD lethality - were utilised to characterise 
feeding related effects of TCDD.
This thesis provides novel information on feeding behaviour and food 
preferences in adult rodents, after single dosing with TCDD. It was shown 
that novel food aversion and decreased food intake are two different 
phenomena. TCDD-induced novel food item aversion (especially to 
chocolate) was sensitive, rapid, and long lasting - if the novelty was offered 
simultaneously with TCDD. Avoidance was missing in AHR-knockout mice. 
AHR activation thus seems to enhance survival by leading to rejection 
of foods which appear as harmful by inducing metabolism. Collectively, 
the experiments suggest interplay between the AHR and the regulatory 
pathways of feeding.
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FOREWORD 
 
”Department of Environmental Health at the National Public Health Institute (KTL), 
and its Laboratory of Toxicology started in Kuopio in the year 1983. In that 
laboratory, Raimo Pohjanvirta and Jouko Tuomisto made an interesting finding of a 
1000-fold sensitivity difference in several forms of dioxin toxicity between outbred 
Han/Wistar and inbred Long-Evans rat in 1980s. Since then, this animal model has 
been utilised in many ways to enhance the knowledge of complicated mechanisms 
of dioxin toxicity in the highly complicated physiological organisms. Toxicity 
studies have made an enormous contribution for the sound and sophisticated health 
risk assessment of dioxins and of other agents that surround us in everyday life, such 
as many chemical compounds in food and water, cosmetics, drugs, and toys. In 
mechanistic toxicology and in many other fields of science animal experiments are 
esssential. While recognising the importance of “real-life” studies, we have to 
recognise that animals are living creatures, and their well-being and humane 
treatment are essential. This is even necessary to ensure good quality research 
results. This appreciation has been an important part of the working philosophy.   
 
One circle closes with this thesis. It appears to be the last in the series of published 
dissertations in the THL (previously KTL), and the last using the differently dioxin-
responsive rats in the now closed animal unit in the Laboratory of Toxicology. We 
are living in the world where the winds of change are continuously blowing. Despite 
any change in our society, in research organisations and funding agencies with their 
funding policies, I wish there will always remain wisdom to acknowledge the 
importance of toxicological research.”    
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Abstract 
Sanna Lensu. No Chocolate, Please! Dioxin-Induced Responses in Feeding Related 
Behaviour and in Neuronal Activity. National Institute for Health and Welfare 
(THL). Research 146. 185 pages. Kuopio, Finland 2014.  
ISBN 978-952-302-353-6 (printed), ISBN 978-952-302-354-3 (online publication)  
 
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is the most potent member of a family 
of persistent organic pollutants called dioxins. These chemicals are highly toxic (at 
pico- and nanogram level), stable, and resistant to biological degradation in the 
environment. Human exposure to these compounds occurs mainly via ingestion of 
meat, fish and dairy products, as dioxins accumulate in the food chain. Since they 
have extremely long elimination halflives in humans their levels in adipose tissue 
increase throughout the lifespan. A key mechanism in mediating the effects of 
dioxin is binding to the intracellular aryl hydrocarbon receptor (AHR). 
AHR is an ancient protein involved in many biological processes such as in several 
stages during development, but also in angiogenesis, in circadian clockwork, 
apoptosis, immune system function, and in metabolism – e.g. xenobiotic and fat 
metabolism. When activated by dioxins AHR participates in many cellular events. In 
the mice lacking AHR (AHR-knockout mice), dioxin does not exert any effects; in 
other living organisms the effects of dioxin are strongly dependent on dose, animal 
species and strain, gender and developmental stage, and observation time. In 
humans, chronic exposure to these endocrine disrupting chemicals has been 
postulated to play a role in the current obesity epidemic, and other metabolic 
disorders such as type II diabetes. In laboratory animals, one of the striking, dose-
dependent effects of acute TCDD exposure is weight loss due to severely diminished 
food intake.   
In this thesis, TCDD induced feeding related behavioural effects were studied in 
detail and the brain activated areas were screened. Experiments utilised rodent 
models with different AHR structures or expression levels and thus, with different 
sensitivities to TCDD lethality. At present, the most sensitive effects of dioxins are 
seen in the developing fetus, but here it was showed that in adult animals, the 
aversive response to a novel food item offered in close temporal proximity with 
TCDD, was an extremely sensitive, rapid, and longlasting response. This 
phenomenom appeared at equally low dose levels in all animals, independent of 
their sensitivity to dioxin lethality. The aversive response was missing in AHR-
knockout mice. Thus, it seems that the housekeeping role of AHR is extended to 
behaviour: activation of AHR leads to rejection of such foods which appear as 
harmful by inducing metabolism, and thereby AHR activation enhances survival. 
Furthermore, by developing an automated system to follow ingestive patterns on a 
minute-to-minute basis, the diminished food intake was characterised in detail in 
sensitive Long-Evans and in resistant Han-Wistar rats. These studies revealed 
different feeding and drinking behavioural patterns over the day, with and without 
TCDD, evidence that there is interplay between the AHR and the circadian 
clockwork in the regulation of feeding. Regulatory pathways of these effects in brain 
and in periphery deserve further investigation.  
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The results implicate that TCDD induces two different feeding responses which both 
seem to be mediated by the AHR, but which occur at widely different doses. The 
one is related with the regulation of normal food intake and the other is related with 
the aversive response. The latter of these two is extremely sensitive occurring at the 
doses that do not affect normal food intake of animals. Physiological role of the 
AHR in mediating the aversive response is an interesting novel finding, and might 
be of importance for the development of medical treatment of anorectic diseases, 
such as cancer cachexia. 
  
Keywords: 2,3,7,8-Tetrachlorodibenzo-p-dioxin, TCDD; dioxin; feeding; drinking; 
behavioural patterns; aversive behaviour; neophobia; Aryl hydrocarbon receptor, 
AHR; rat; mouse 
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Tiivistelmä 
Sanna Lensu. Ei suklaata, kiitos! Dioksiinialtistuksen vaikutuksia syömis- ja 
juomiskäyttäytymiseen sekä neuronaaliseen aktiivisuuteen. Terveyden ja 
hyvinvoinnin laitos (THL). Tutkimus 146. 185 sivua. Kuopio, Finland 2014.  
ISBN 978-952-302-353-6 (painettu), ISBN 978-952-302-354-3 (verkkojulkaisu) 
 
Dioksiinit ovat erittäin pysyviä ja laajalti levinneitä kemikaalisaasteita, joita 
ympäristössämme on käytännössä kaikkialla. Dioksiineja syntyy mm. epätäydellisen 
palamisen seurauksena polttoprosesseissa. Ihmiset altistuvat näille haitallisille 
klooriyhdisteille pääasiassa ruuan välityksellä, koska dioksiinit ovat rasvaliukoisia ja 
niin ollen kertyvät ravintoketjuissa. Ihmisen elimistöstä poistumisen pitkä, vuosia 
kestävä puoliintumisaika aiheuttaa sen, että dioksiinikertymä lisääntyy koko eliniän 
ajan. Haittavaikutukset riippuvat altistumistavasta, -annoksesta ja yksilöllisistä 
tekijöistä, mutta haitallisten vaikutusten syntymiseen riittävät erittäin pienet 
annokset dioksiinia (pg ja ng, milligramman miljoonasosat). Tyypillistä on, että eri 
lajien ja eläinkantojen välillä on suuria herkkyyseroja, ja nämä herkkyyserot ovat 
riippuvia myös toksisesta tai biologisesta vasteesta. Dioksiininkaltaisia kemikaaleja 
on useita, mutta kaikkein myrkyllisin on 2,3,7,8-tetraklooridibentso-p-dioksiini 
(TCDD). 
Suurin osa dioksiinien biologisista vaikutuksista välittyy aryylihiilivetyreseptorin 
(AHR) välityksellä. Jos eläimillä ei ole toimivaa AH-reseptoria, ne eivät reagoi 
dioksiinialtistukselle juuri lainkaan. Lisäksi aiemmissa tutkimuksissa on havaittu, 
että koe-eläinten Ahr geenin ja toistaiseksi tuntemattoman B-geenin genotyypit 
vaikuttavat TCDD-herkkyyteen. AH-reseptorilla on myös fysiologisia tehtäviä 
elimistössä, kuten esimerkiksi vuorokausirytmien säätelyyn osallistuminen.  
Yksi dioksiinialtistuksen vaikutuksista on näivettyminen: eläimet lakkaavat 
pikkuhiljaa syömästä, laihtuvat ja näivettyvät pois. Näivettyminen johtaa TCDD-
annoksesta ja eläimen herkkyydestä riippuen kuolemaan, mutta yhä edelleen 
varsinainen akuutti kuolinsyy on tuntematon. Mikäli annos ei ole tappava, joidenkin 
päivien kuluttua eläimet ryhtyvät syömään, mutta niiden paino jää pysyvästi 
kontrollieläimiä matalammaksi. Nämä TCDD-altistuksen aiheuttamat syömisvaikutukset 
ovat tyypillisesti sellaisia, että niissä voidaan nähdä suuria herkkyyseroja riippuen 
eläimen lajista ja genotyypistä.  
Tässä kokeellisessa työssä käytettiin malliaineena TCDD:tä tutkittaessa yhden kerta-
altistuksen vaikutuksia koe-eläinten syömis- ja juomiskäyttäytymiseen ja solujen 
aktivaatioon aivoissa. Työssä käytettiin eri tavalla TCDD:lle herkkiä eläimiä: 
resistenttejä Han/Wistar (H/W) rottia, herkkiä Long-Evans (L-E) rottia ja niiden 
risteytyksiä sekä hiiriä. Hiiret olivat normaaleja villityypin C57BL/6-hiiriä tai 
C57BL/6-hiiriä, joilta Ahr-geeni oli poistettu. Tutkimuksessa kävi ilmi, että Ahr:n 
genotyypistä riippuen syömiskäyttäytyminen oli hyvin erilaista niin 
altistamattomilla kuin TCDD-altistetuilla eläimillä. Eroja oli mm. 
syömisaktiivisuuden vuorokausirytmissä ja aterioiden tiheydessä ja koossa. Työssä 
tutkittiin myös makuaversiota eli uuden ruoka-aineen välttämistä TCDD-altistuksen 
jälkeen. Tähän asti on oletettu, että TCDD-altistuksen aiheuttamat akuutit, nopeasti 
ilmenevät vaikutukset rajoittuvat solu- ja molekyylitasolle. Työssä selvisi, että 
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TCDD:n aiheuttama makuaversio on erittäin herkkä, nopea, ja kauan säilyvä 
biologinen vaste eikä se riipu eläimen herkkyydestä TCDD:n letaalisuudelle. 
Erityisen voimakkaan aversion tuotti suklaa, kun sitä tarjottiin eläimille samaan 
aikaan dioksiinialtistuksen kanssa uutena ruoka-aineena. Työssä selvitettiin myös 
mitkä aivoalueet aktivoituvat dioksiinialtistuksen jälkeen. Histologisen työn 
löydökset eivät kuitenkaan selitä käyttäytymisessä havaittuja ilmiöitä, ja näin ollen 
TCDD:n akuutit vaikutukset ruokahalun säätelyyn vaativat lisätutkimuksia.  
Tämän väitöstyön merkittävä löydös oli se, että dioksiinialtistuksella havaittiin 
olevan kaksi erityyppistä vaikutusta syömiseen, ja nämä vasteet ilmenevät hyvin 
erilaisilla annostasoilla ja eri tavoin tutkituissa eläimissä. Toinen ilmiöistä liittyy 
ruokahalun säätelyyn: annos-vasteiseen syömisen vähenemiseen ja joko kuolemaan 
tai pysyvästi alentuneesen ruumiin painoon. Makuaversio oli hyvin herkkä vaste 
kaikissa tutkituissa eläimissä eivätkä tutkimuksessa käytetyt TCDD-annokset 
vaikuttaneet eläinten normaaliin ruokahaluun lainkaan. Makuaversion tiedetään 
liittyvän paitsi maistamiseen ja syömiseen, myös oppimiseen ja muistiin olennaisella 
tavalla. Keskushermosto on tärkeä tutkimuskohde sekä ruokahalun säätelyssä että 
muistissa ja oppimisessa, ja yksi tulevaisuuden haaste onkin selvittää 
ympäristömyrkky TCDD:n vaikutuksia aivoissa nykyistä tarkemmin.  
Nämä tutkimukset antavat myös uusia viitteitä AH-reseptorin fysiologisista 
tehtävistä elimistössä. Tulosten perusteella vaikuttaa siltä, että AH-reseptori 
osallistuu syömisen säätelyyn, joko suoralla vaikutusmekanismilla tai esimerkiksi 
vuorokausirytmin säätelyn välityksellä. Toisaalta havaittiin, että hyvinkin pienillä 
TCDD-annoksilla tapahtuva AH-reseptorin aktivoituminen johtaa sellaisen ruuan 
välttämiseen, jota tarjottiin uutena ja yhtä aikaa altistuksen kanssa. Koska monet 
AHR:ää aktivoivat haitalliset aineet joutuvat elimistöön ruuan välityksellä, voidaan 
olettaa, että AHR:n aktivoituminen matalilla annostasoilla johtaa sellaisen ruuan 
välttämiseen, joka on aiheuttanut AHR:n aktivoitumisen. Toisin sanoen löydökset 
viittaavat siihen, että AHR:llä olisi myös suojaavia vaikutuksia: kun ruuan mukana 
tulleet aineet saavat aikaan AHR:n aktivoitumisen, kyseistä ruokaa ei enää syödä 
kertamaistamisen jälkeen. Tällä havainnolla voi olla merkitystä kehitettäessä 
lääkehoitoja, joilla voidaan parantaa monien sairauksien (esim. syöpä) yhteydessä 
ilmenevää heikentynyttä ruokahalua.  
 
Avainsanat: 2,3,7,8-Tetraklooridibentso-p-dioksiini, TCDD; dioksiini; syöminen; 
juominen; aversiokäyttäytyminen, välttämiskäyttäytyminen; neofobia, uuden ruoka-
aineen välttäminen; aryylihiilivetyreseptori, AHR; rotta; hiiri 
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Abbreviations 
AHR Aryl hydrocarbon receptor (protein), AH receptor 
Ahr The gene encoding AHR 
Ahr -/- AHR knock out (AHRKO); both alleles of Ahr are inactivated  
Ahr b/b Allele of Ahr locus; high affinity allele; found in TCDD-
responsive C57BL/6JKuo mice   
Ahrhw/hw Han-Wistar –type allele of Ahr locus; related with resistance to 
acute toxicity and found in TCDD-resistant H/W rats and in line 
A rats   
Ahrwt/wt Wild-type allele of Ahr locus; found in most rat strains sensitive 
to toxicity of TCDD, e.g. present in L-E rats  
AHRR AHR repressor; inhibits AHR function by insufficiently 
elucidated mehanisms 
Arc Nucleus arcuatus of hypothalamus in the brain 
ARNT AHR nuclear translocator; dimerizes with AHR and this 
heterodimer binds to DNA 
B An unknown gene B that affects TCDD-sensitivity 
Bhw/hw Han-Wistar –type allele of unknown B gene that affects TCDD-
resistance; expressed in H/W rats (resistant) and in line B rats 
(moderately resistant to toxicity of TCDD) 
BBB Blood-brain barrier 
bHLH/PAS Basic helix-loop-helix /PAS [homologous region found in 
proteins period (PER), ARNT and single-minded (SIM)]: AHR 
belongs to this family of transcriptional regulators 
BMAL-1 Brain and muscle aryl hydrocarbon receptor nuclear translocator 
(ARNT)-like protein 1, positive circadian rhythm regulator 
CD36 Cluster of Differentiation 36, fatty acid translocase 
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CEA Central nucleus of amygdala  
c-Fos Protein product of immediate early gene c-Fos; used as an early 
marker of cellular activity 
clock, clockwork General term for circadian regulation  
CLOCK Circadian locomotor cycles kaput, positive circadian rhythm 
regulator  
Cry Cryptochrome, repressive protein in circadian regulation 
CS Conditioned stimulus 
CTA Conditioned taste aversion 
CYP Cytochrome P450: xenobiotic metabolising enzymes – members 
of a CYP superfamily 
C57BL/6JKuo Mouse strain (bred in Kuopio); sensitive to the effects of dioxin 
DBA/2 Mouse strain resistant to the dioxin effects 
DRE Dioxin (xenobiotic) responsive element in DNA: a specific 
sequence of DNA that binds the AHR-ARNT complex 
ED50 Effective dose 50%: the dose that is estimated to give 50% of 
the maximal response or the dose that achieves a response in 
50% of dosed animals 
efficacy Intrinsic activity; ability to activate the receptor or magnitude of 
an effect; capacity of a compound to produce an effect 
EROD Ethoxyresorufin-O-deethylase; EROD activity is almost 
exclusively due to the enzyme CYP1A and therefore can be 
used as a tool to measure CYP1A-enzyme activity 
FFA Free fatty acid 
GI Gastrointestinal  
GLP-1 Glucagon-like-peptide 
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H/W Han/Wistar (Kuopio) rat strain; originally inbred but currently 
random bred strain; resistant to most effects of TCDD 
IC Insular cortex 
i.g. Intragastric administration 
i.p. Intraperitoneal administration 
LD50 Lethal dose 50%: the dose that is estimated to kill 50% of 
animals in an acute toxicity test 
L-E Long Evans (Turku /AB) rat strain; sensitive to most effects of 
TCDD 
Line A rat A cross-bred rat line (H/W x L-E); assumed genotype Ahrhw/hw 
Bwt/wt; very resistant to most effects of TCDD  
Line B rat A cross-bred rat line (H/W x L-E); assumed genotype Ahrwt/wt 
Bhw/hw; moderately resistant to most effects of TCDD 
Line C rat  A cross-bred rat line (H/W x L-E); assumed genotype Ahrwt/wt 
Bwt/wt; sensitive to most effects of TCDD 
NAcc Nucleus accumbems 
NBM Nucleus basalis magnocellularis in the brain 
NPY Neuropeptide Y 
NTS Nucleus tractus solitarius 
PAH  Polycyclic aromatic hydrocarbon  
PaVN Paraventricular nucleus of hypothalamus 
PBN  Parabrachial nucleus in the brain 
PCB Polychlorinated biphenyl 
PCDD Polychlorinated dibenzo-p-dioxin 
PCDF Polychlorinated dibenzofuran 
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Per Period, repressive protein involved in circadian regulation 
potency A measure of the concentration or the dose eliciting an effect; 
affinity to a receptor – the higher potency the lower 
concentrations of a compound needed to occupy the receptor 
SCN Suprachiasmatic nucleus of the brain 
SIRT1 Silent mating type information regulation 2 homolog 1; member 
of the sirtuin family of proteins that function as NAD+-
dependent protein deacetylases or ADP-ribosyltransferases 
TCDD 2,3,7,8-tetrachlorodibenzo-p-dioxin: the most potent congener 
of dioxins and therefore often used as a reference compound of 
dioxins 
TEF  Toxic equivalence factor; factor used to compare dioxin-like 
compounds according to their potency to induce effects in 
relation to TCDD (whose TEF-value = 1) 
US  Unconditioned stimulus, stimulus provoking e.g. GI-illness 
VMH Ventromedial hypothalamic nucleus of the brain 
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1 Introduction 
Each of us must eat and breathe to stay alive. In addition to compounds essential for 
life, foodstuffs and the inhaled air contain unwanted products such as environmental 
contaminants. In many respects, archetypes of these agents are dioxins, which are 
widely distributed and stable in our environment.  
Dioxins and other dioxin-like halogenated hydrocarbons are chemicals that strike 
fear into the general public. They are believed to cause harmful effects, even cancer: 
The International Association for Research on Cancer has classified the most potent 
compound of the dioxins, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), as a human 
carcinogen (group 1; 1) at extremely low amounts. Widespread public concerns 
about the presence of DDT and other environmental persistent contaminants were 
raised by Rachel Carson who published the book ‘Silent Sping’ at 1962. Since then, 
efforts to reduce environmental emissions of harmful agents including dioxin-like 
compounds have resulted in a lowering of concentrations in humans. The amounts 
of these chemicals to which humans can be exposed is regulated by the authorities; 
in the United States by the Environmental Protection Agency since 1985 2. 
Nevertheless, despite of all the efforts to limit the intake of dioxins, these 
compounds have attracted extensive public attention regularly and tragic cases of 
food contaminations or even deliberate poisonings have been news headlines 
throughout the world. The latest case emerged in Europe during January 2011, when 
animal feed in Germany was found to have been contaminated with dioxins. 
The risk assessment of dioxins is challenging due to the strong dependence of the 
biological responses on many factors such as species, strain, age or developmental 
stage, sex, or tissue 3, 4. The knowledge of these compounds has emerged from 
detailed mechanistical and epidemiological studies. For the latter, an important 
source of information has been studies conducted after the explosion at a chemical 
factory in Seveso 1976. One crucial initial finding was an appreciation of the key 
mechanism of action: practically all of the biological effects of these compounds: 
involve their binding to the intracellular aryl hydrocarbon receptor (AHR) 5, 6. This 
is currently one cornerstone of dioxin risk assessment. AHR is phylogenetically a 
highly conserved protein and an important mediator of xenobiotic responses. 
However, a variety of pysiological functions has been found to involve AHR 
mediation highlighting its importance also in normal physiological systems. In deed, 
those include modulation of cell function and participation in the development of the 
brain and vasculature 7-9. Further physiological roles of AHR, together with the 
physicochemical and structural characteristics of AHR ligands have been 
extensively studied, because an awareness of AHR-mediated pathways enhances our 
understanding of many toxic and biological events.   
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Despite numerous studies of the impacts of dioxin, there are also some responses 
that have remained rather elusive. One of these is the wasting syndrome: a dose-
dependent reduction of body weight, permanently retarded growth and hypophagia 
in dioxin-exposed laboratory animals following even a single dose 10, 11. Although it 
is rare that chemicals evoke these kinds of effects, another surprising feeding related 
behavioural observation has been made: exposure to TCDD caused avoidance of 
highly palatable food items such as chocolate 12. 
Food intake and feeding behaviour have attracted increasing research interest 
during the past 10 – 20 years. This is not attributable to dioxins but instead it is due 
to current obesity epidemic spreading throughout the world. There are many 
unknown reasons, why the current western lifestyle – i.e. lack of physical exercise in 
automated environment combined with excessive availability of energy-rich food – 
has overwhelmed the physiological control of appetite and body-weight regulation. 
Huge research efforts have been spent in clarifying the key mechanisms in the 
control of energy homeostasis; however, the issue is complicated by the fact that 
feeding is much more than the intake of adequate amount of calories to meet 
metabolic needs. Learning and memory, and other non-metabolic factors such as 
food reward and its hedonic value are thought to play an important role in food 
intake, and both neural and peripheral systems participate in the complex control of 
energy balance regulation (reviewed e.g. 13-17). 
Food intake and the regulation of energy balance – even without dioxin exposure 
- are very seldom linked to a single gene but instead they involve a variety of genes 
and their interactive interplay throughout the day. Therefore experimental in vivo –
models provide essential tools to study the energy balance, and behaviour in this 
context is an important parameter. In this thesis, several animal models, with known 
differences in the AHR structure or expression levels, were used to study feeding 
related responses after TCDD exposure, especially after low sublethal TCDD doses. 
These experiments intended to evaluate whether the AHR could be involved in 
mediating responses related to feeding behaviour. Moreover, although TCDD has 
dramatic effects on altered energy homeostasis and behaviour, many aspects of its 
properties on feeding related behaviour have remained poorly studied. In that 
respect, the studies in this thesis represent steps forward in understanding the dose-
responsive effects of dioxin and providing clues to the AHR as one piece in the 
totality of factors involved in energy balance. 
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2 Review of the literature 
2.1 Dioxins  
The term ‘dioxin’ is rather inaccurate and it includes several chemicals: 
polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated bibenzofurans 
(PCDFs) and dioxin-like polychlorinated biphenyls. These compounds share not 
only structural similarities (Fig. 1), but also physical and biological characteristics, 
namely binding to an intracellular protein, the aryl hydrocarbon receptor (AHR, 
Chapter 2.2). These chemicals contain numerous congeners and isomers, but only 
those PCDDs and PCDFs having chlorine in lateral substitutions at positions 2,3,7,8 
and coplanar PCBs (unsubstituted or monosubstituted in the ortho-positions, Fig. 1) 
are able to adopt a planar position and to induce dioxin-like toxicity. Among the 
dioxins, the potencies to induce (toxic) effects differ, and therefore the most potent 
congener, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), is often used as a reference 
compound of dioxins 18-20. 
 
Figure 1. Main structures of different dioxin congeners, and structure of the most 
potent congener, 2,3,7,8-tetrachlorodibenzo-p-dioxin. 
All dioxin-like congeners need to be taken into account in the dioxin health risk 
assessment because usually they appear in mixtures, and exposure to a single dioxin-
type pollutant rarely happens. For risk assessment purposes, if one wishes to 
characterise the toxicity of each dioxin congener and their mixtures, then it is 
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customary to estimate toxicity equivalence factors (TEFs). The TEF is a relative 
potency factor which has been assigned to each congener possessing dioxin-like 
toxicity and it is calculated relative to TCDD, which has the value of 1. Hence, TEF-
values of dioxin-like compounds vary from 0.00003 to 1. TEFs are also commonly 
used in the dose-metrics in the dioxin literature, although originally the values were 
defined for risk management by an expert committee, which took account the 
existing scientific data and assumptions 21, 22. The total sum of all partial equivalents 
in the mixture (toxic equivalent, TEQ) can be calculated by summing up the amount 
or concentration of an individual compound multiplied by its TEF. It is important to 
appreciate that the TEF methodology is valid only if the chemicals have been 
structurally well defined, exhibit additivity, and they produce the same toxicity 
through the same mode of action 21, 23. 
 All dioxins are effective at extremely low concentrations (at pg and ng levels). 
Responses vary (in vivo and in vitro), and there are several factors determining 
sensitivity differences (described later in Chapter 2.1.3.1) which complicate the 
mechanistic studies of dioxins. However, mechanistic studies represent the 
foundation for the sound but challenging risk assessment of dioxins 21, 24.  
2.1.1 Sources and properties of dioxins 
Dioxins are a ubiquitous and feared group of persistent organic pollutants 
(abbreviated to POPs). In practice, dioxins can be found everywhere. PCB-
compounds have been utilized as technical oils e.g. in hydraulic and electronical 
equipment and as plasticizers in the plastic industry until the 1980s. Although 
PCDDs and PCDFs have never been intentionally made (except for scientific use), 
they are easily formed in the burning processes in the presence of chlorine and 
oxygen. Hence, they are able to end up in the environment as unwanted and harmful 
by-products e.g. in the production of PCBs and chlorophenols, waste incineration, 
metal industry, and chlorine-based bleaching-processes. While industrial dioxin 
pollution is nowadays strictly controlled, uncontrolled burning at low temperature is 
still a present-day source of dioxins. An example of this is a dumpsite fire or burning 
of wastes in an uncontrolled manner (Fig.2) 25, 26. 
Once these chemicals are produced, they are extremely stable, resistant to 
biological degradation, and they remain in the environment since they become 
bound to particulate matter (usually first in the air and then in the sediments) where 
they remain for ages 27, 28. They are poorly soluble in water and even in organic 
solvents 29, 30. Dioxins accumulate in the food chain. In the environment, they are 
very slowly broken down by ultra-violet radiation and biodegradation 31.    
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Figure 2. Increasing recycling of e-wastes and their illegal or accidental 
incineration are potential sources of dioxins, constituting a global 
environmental hazard. 1 
2.1.2 Absorption, distribution, metabolism, and excretion (ADME) of 
dioxins   
Dioxins are fairly well absorbed from the gastrointestinal (GI) and pulmonary tracts 
32, 33, and penetration via skin is also possible, although relatively slow 34, 35. 
Generally, the extent of absorption is critically dependent on the solubility of 
dioxins, whereas the administration route has only a minor role 36, 37. Once inside the 
body, they are transported in blood and lymph associated with chylomicrons and 
lipoproteins, and rapidly deposited in the liver and fat. In these tissues, they 
accumulate in lipid droplets, lipoproteins, and in mitochondria. In liver, dioxins bind 
avidly to cytochrome-P450 protein 1A2 (CYP1A2). Their metabolism is slow and 
the elimination follows first-order kinetics. In humans and in most other mammals, 
dioxins are mainly excreted in the faeces 38. 
There is only some data about congener specific half-lives, and it appears that 
they differ. Elimination rate depends on species and developmental stage, i.e. 
elimination is faster in the young than in grown-up individuals. Furthermore, high 
doses (or repeated exposures) seem to induce elimination and accelerate the rate of 
dioxin elimination 39. In general, these compounds have long elimination half-lives, 
                                                        
 
1 Figure from:  http://nagesh-biradar.blogspot.com/ (Creative Commons Attribution-NonCommercial-
ShareAlike 3.0 Unported License)  
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ranging from 12 to 31 days in the rat and from 5 to 11 years in humans 38, 40, 41. In 
human beings the body burden increases every year; by the time an individual is 
about 60 years old, there has been a 5- to 10-fold increase in their concentrations in 
the body 42, 43. 
Because of all these issues, the bioavailability of dioxins is important with the 
exposure: although these compounds can be found even at high levels in the 
environment, only the amount gaining access to the body (body burden) is able to 
exert effects. Nevertheless, although the body burden would be the most optimal 
surrogate for the dose metrics of  dioxins, this information is very rarely available 44.  
2.1.3 Toxic responses in experimental animals 
After a dioxin exposure, the induction of metabolic enzymes as well as up- or down-
regulation of other AHR mediated genes occurs rapidly 45-48, but lethality even after 
a high dose takes at least a week, and there is a wide variety between animals 
(Chapter 2.1.3.1) 49, 50. In most vertebrates, dioxin exerts many responses i.e. both 
hypoplastic and atrophic as well as hyperplastic and proliferative effects. In general, 
some responses can be considered as adaptive (such as induction of metabolic 
enzymes), whereas some of them are clearly harmful and lead to death in a dose-
dependent manner (e.g. reviewed 3, 51-53). Despite numerous studies examining the 
toxic effects of TCDD, the critical factor(s) responsible for death have remained a 
mystery. A peculiar wasting syndrome precedes death: dose-dependent diminished 
feeding, severely disturbed lipid metabolism and profound weight loss. In addition, 
rather high doses of TCDD have been shown to induce an aversion towards novel 
food items and to alter food preferences. These feeding related outcomes will be 
described in more detail in Chapter 2.4.  
Dioxins exert toxicity by acting on many cellular signaling systems, such as 
protein kinases, cytokines, and growth factors, as well as altering the function and 
concentration of receptors. They also alter the phosphorylation patterns of proteins 
regulating cell cycle and apoptosis 54. The effects on the endocrine system include 
accelerated elimination and impaired synthesis of hormones. However, the effects 
are dependent on the dose, the studied organism and its sensitivity to dioxins, 
combined with the time of observation. Moreover, the effects are somewhat tissue 
specific, as different tissues concentrate TCDD differently. Many of the effects are 
secondary to the wasting syndrome encountered with high doses 3. 
Dioxins are non-genotoxic carcinogens (as demonstrated in animals) but this 
effect is seen only at relatively high doses when compared to the general toxicity 55. 
Although dioxin exposure is linked to a higher risk of many cancers 56, initiation of 
carcinogenesis seems to be secondary to tissue damage. It has been shown that 
dioxin induced oxidative stress, and the production of reactive oxygen species 
contribute to the DNA damage in many tissues 57-59. 
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The most sensitive effects of dioxins seem to be developmental defects. These 
compounds can pass through the placenta and are present in the mother’s milk 60, 61. 
Although there are still uncertainties of exact timing and mechanisms through which 
TCDD exerts these adverse effects, non-toxic (< 1 µg/kg) maternal dioxin exposure 
has been shown to cause developmental delays and to harm male reproductive 
system 62-64. There are also other low dose (< 1 µg/kg) prenatal exposure effects e.g. 
disturbances in neuroendocrine functions and brain development 65, 66, interfering 
with learning and memory 67-69. Nevertheless, these behavioural effects in animals 
are restricted to in utero and lactational exposure; in adults much less research has 
been conducted, and it seems that other behavioural responses than those related to 
feeding are missing 70.   
2.1.3.1 Factors affecting sensitivity differences between animals 
Sensitivity to the toxic effects of dioxin differs not only between species but even in 
substrains, as well as during development. According to the literature, sensitivity to 
lethality ranges from the most sensitive lake trout sack fry [LD50 value (lethal dose 
killing 50% of exposed animals) of 0.074 µg/kg, injected into egg 71] to the most 
resistant animal, adult male Han/Wistar rat subsrain (H/W; Kuopio, LD50 value well 
above 9600 µg/kg 72, 73). The LD50 value of the most sensitive rat substrain, an 
originally inbred (later random-bred) Long-Evans rat (L-E, Turku/AB) is about 7 
µg/kg for females and about 18 µg/kg for males 50, 73. In other words, this rat model 
showed about a 1000-fold difference in the sensitivity within the same species. Ahr-/- 
mice, originating from the C57BL/6-mice strain, are largely unresponsive to TCDD 
effects 74, 75, but in most mice strains LD50 values vary from 150 to 300 µg/kg 3. For 
the resistant DBA/2 strain lethal dose is 2600 µg/kg  while the corresponding value 
for the C57BL/6J mice is about 180 µg/kg 49. Gender also affects sensitivity: in rats, 
females are more sensitive than males 50, 73, 76 whereas in mice, the situation appears 
to be reversed (at least in some substrains) 77. Furthermore, age and developmental 
stage are important determinants: Not only are the differences in embryo/fetal 
toxicity or in early postnatal toxicity among species and strains much smaller 78, but 
the developing individuals are also much more sensitive than the adults (e.g.64, 79). 
There are convincing data indicating that the wide variety in responses cannot be 
solely explained by kinetic differences in the metabolism and excretion of TCDD. 
Intra- and inter-species differences mostly involve the AHR, but there do seem to be 
some  additional, still unknown, factors determining the toxic outcome (reviewed in 
10). In many animals, the ligand binding affinity to AHR accounts for the response 
sensitivity: this applies to mice and birds and explains within-species sensitivity 
differences 49, 80, 81. The 10-fold difference between C57BL/6J and DBA/2 mice in 
TCDD toxicity as well as in sensitivity to the biochemical effects results from the 
polymorphism in the ligand binding domain of AHR of the resistant DBA/2 mouse 
(Fig. 3A) causing diminished affinity in ligand binding 82. In the resistant H/W rats, 
the mutated AHR is smaller protein than that of the sensitive L-E rats 83, but the 
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binding affinity of TCDD to AHR does not differ between the strains 84. Generally, 
in mice all responses to TCDD show similar sensitivity differences whereas in 
resistant H/W rats, some responses occur equally (type I dioxin effect, e.g. 
induction of metabolic enzymes) in sensitive L-E rats while some others (type II 
dioxin effect, e.g. lethality, wasting and diminished feeding) differ 3, 85. The 
mechanism behind these different efficacies among responses is not fully 
understood, but alternative splicing in the transactivation domain at the C-
terminus (Fig. 3A) of the H/W-type AHR apparently makes the ligand-bound 
receptor ineffective at acting as a transcription factor. In support of this proposal, 
there are the numerous differences noted in responses and in AHR-mediated 
regulation of gene transcription between the two strains 45, 46, 86.  
In an attempt to clarify the unknown factors and the roles of resistance genes in 
TCDD toxicity H/W and L-E rats were crossbred in our laboratory. The outcome of 
crossbreeding was three rat lines with different types of resistance related genes, Ahr 
and an unknown gene B. Line A rat has a mutated H/W type allele of Ahr and wild-
type B allele (genotype Ahrhw/hw, Bwt/wt). The genotype of line B rat turned out to be 
Ahrwt/wt, Bhw/hw, whereas line C rat possesses neither of the resistance alleles (Ahrwt/wt, 
Bwt/wt). The unknown gene B is associated with resistance since the rats carrying the 
Bhw allele are intermediately resistant to TCDD 73, 87.  
2.2 Aryl Hydrocarbon Receptor (AHR) 
The aryl hydrocardon receptor is an intracellular, ligand-dependent transcription 
factor having a modular structure (Fig. 3A). It belongs to basic Helix-Loop-
Helix/Periodic, AHR nuclear translocator, Single-minded (bHLH/PAS) proteins. 
Several transcriptional activators, and importantly, repressors are associated with 
regulating transactivation of these proteins, and they are involved in developmental 
and adaptive processes 88. PAS domain proteins [e.g. period’s (PER) homologs, 
single-minded’s (SIM) homologs, and hypoxia inducible factors (HIFs)] have 
multiple roles in neurogenesis and in environmental adaptation: hypoxia, circadian 
rhythms, and xenobiotic metabolism to mention but a few 89, 90.  
The responses to AHR activation are mediated via canonical (also known as 
classical) and non-canonical signaling pathways (see Fig. 3B), although these may occur	  simultaneously	  and	   they	  both	  affect	   the	   final	  outcome.	  The	   toxic	  effects 
arise from abnormal activation or dysregulation of target genes of the AHR. The 
best-known pathway for the AHR is the activation via classical, canonical pathway 
by ligand binding (Fig. 3), typically leading to induction of metabolic phase I 
enzymes [enzymes in cytochrome P450 family: CYP1 family and also CYP2A1)] 
and phase II enzymes (e.g. 91, 92). The involvement of AHR in xenobiotic responses 
and in biology will be briefly described in chapters 2.2.1 and 2.2.2, a more 
comprehensive information of multiple roles of AHR in biology and toxicology can 
be found in the recently published book edited by Prof. Pohjanvirta 93.  
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2.2.1 Activation of AHR – mediator of xenobiotic responses 
The AHR is the only vertebrate member of the bHLH/PAS family that is known to 
bind and to be activated by small chemical ligands. The binding of a ligand into a 
receptor protein (Fig. 3B) is like a key opening secondary effects, up- or 
downregulation of gene transcription. In short, ligand-binding is followed by AHR 
entry in the cell nucleus, chaperone proteins are dissociated, and AHR 
heterodimerises with another bHLH/PAS protein, Ah receptor nuclear translocator 
(ARNT). The heterodimerised complex binds further to xenobiotic response 
elements (XREs, known also as dioxin response element, DRE or AHR element). 
DNA binding is followed by interactions of the AHR/ARNT dimer with 
transcriptional coregulators 94, 95. There are many AHR regulated genes 46, 91 and 
some of them modulate dioxin kinetics - e.g. induction of CYP1A2 causes dioxin 
accumulation in the liver 96, 97 -  whereas some regulate AHR function: induction of 
AHR nuclear repressor (AHRR) inhibits the transcriptional activity of AHR 98. This 
inhibitory mechanism of AHRR seems to be more complicated than originally 
thought 99 and the interactions between AHR and AHRR have also appeared to be 
tissue-, cell-, and context-specific (reviewed in 100). The nuclear export and 
ubiquitin-mediated degradation are of importance in the termination of dioxin 
signaling 101, 102. 
The ligand molecule’s planar shape facilitates its binding affinity to the AHR, 
and the ligand’s potency depends to a large degree not only on how well it fits into 
the receptor but also on its persistence and metabolic inactivation. According to a 
structure-activity modelling, it now seems that two different electrical binding 
mechanisms exist for different AHR ligands 103. Furthermore, with the creation of a 
homology model of the ligand binding pocket of AHR and molecular docking 
simulations, it has been demonstrated that certain physicochemical characteristics of 
the internal ligand binding cavity are needed for optimal binding of a high affinity 
ligand, such as TCDD 104, 105. 
AHR activation is also able to induce effects via a non-canonical signaling 
pathway (Fig. 3B), without DRE binding or heterodimerization with ARNT. The 
contribution of the alternative signaling pathways to dioxin toxicity is still far from 
clear, but the interference of AHR with estrogen or androgen receptor or β-catenin 
signaling pathways are examples of this kind of signalling 106.  
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Figure 3. (Continued). A. The ligand binding domain is indicated with TCDD molecule at 
the N-terminal end of AHR. N-terminal end contains also bHLH and PAS domains, 
structures for heat shock protein binding, and for nuclear transport and export. The basic 
region is responsible for DNA binding, the HLH motif is involved in heterodimerization and 
the PAS domain determines the specificity. The transactivation domain at the C-terminus 
is involved in determining the responses following AHR activation. B. The schematic 
figure illustrates the signaling pathways following AHR activation. If not activated, AHR 
with its stabilizing chaperone proteins is present in the cytosol in the protein complex. The 
complex is unable to enter nucleus but is optimal for ligand (such as TCDD) binding (1.). 
In the classical pathway (solid black arrows) ligand binding leads to translocation into the 
cell nucleus, dissociation of chaperone proteins (2.), heterodimerization with ARNT, and 
DNA binding at dioxin response elements (DREs) (3.) affecting the expression of many 
target genes. Activity is terminated by the export of AHR into cytosol, and the ubiquitin-
proteasome mediated degradation (4.). In addition, AHR activation seems to induce 
alternative pathways, to modulate functions of interactive proteins (dashed black arrows; 
non-canonical pathways i.e. effects occurring without DRE binding or heterodimerization 
with ARNT). These include an increase in intracellular Ca2+ levels (5.) that in turn may 
lead to an increase in cyclooxygenase 2, suppression of acute-phase proteins (6.), or (7.) 
AHR can act as an E3 ubiquitin ligase targeting β-catenin, or estrogen or androgen 
receptor for proteasomal degradation.  
Other compounds can also bind to AHR but the ligand binding does not induce 
dioxin-like toxicities. In many cases this is due to their efficient metabolism 107-109. 
Additionally, the previously mentioned structural and electronic differences in the 
binding mechanisms seem to be important 103, 105. Other ligands of AHR include 
many synthetic and naturally occurring planar molecules resembling TCDD in size 
and shape. Examples of these planar compounds and high-affinity ligands are 
polycyclic aromatic hydrocarbons (PAH compounds) or indolo(3,2-b)carbazole. 
Furthermore, there are both endogenous and exogenous ligands, such as flavonoids, 
tryptophan and its metabolites, bilirubin, indirubin, indigo, and arachidonic acid 
metabolites which can act as agonists, partial agonists or antagonists of the AHR 
(reviewed in 110). Interestingly, it has been demonstrated that the very same ligand 
can act (as shown in vitro) as an agonist or an antagonist, depending on the species 
and the origin of the cell line 111.  
It is also possible that ligand binding is not always needed for the activation of 
AHR. An example is the regulation of CYP1 family enzymes, well-known to be 
dependent on AHR, but apparently their induction does not always involve ligand 
binding. That seems to be the case (at least in some species) for omeprazole 112, 113 or 
nicotine 114, 115. In addition, high glucose concentrations 116, cyclic adenosine 
monophosphate (cAMP) 117, or low-density lipoprotein (LDL) 118 have been claimed 
to be capable of activating AHR (in vitro).   
2.2.2 Physiological roles of AHR 
The generation of AHR knockout mice in three different laboratories 75, 119, 120 and 
studies with these animals have provided enlightening information of the 
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physiological roles of AHR. The regulation of AHR in the absence of exogenous 
ligand(s) can be seen as its constitutive activity. The conserved structures of both the 
AHR and its negative repressor, AHRR are thought to reflect their importance in the 
evolution. Although the expression of AHRR is more tissue-specific than that of 
AHR, it may also have physiological roles (at least in regulating AHR and hypoxia 
inducible factor) 100.  
AHR has been shown to be involved in the normal fetal development of many 
tissues 121-123, being especially important in angiogenesis 124, 125. Its ability to 
regulate apoptosis 126 likely contributes to the regulatory role of AHR in many 
biological events, one good example being reproduction 127, 128. In malignant and 
non-malignant cell migration 129-131 there are several additional proteins participating 
in the actions of AHR. For example, AHR and estrogen receptor interact in many 
ways, and it has been shown that by increasing degradation of estrogen receptor or 
β-catenin, in some cases AHR may even act as a tumour suppressor 132, 133. AHR is 
involved also in the regulation of autoimmunity and in the maintenance of normal 
immune functions 134-137. The possible role of AHR in the circadian regulation will 
be discussed in Chapter 2.4.2. 
AHR-deficient mice are viable but have reduced fertility 128 and a 40 – 50% 
neonatal lethality. They also seem to be susceptible to premature degeneration 121 
along with shortened life expectancy 138. Studies show them having depleted splenic 
lymphocytes, a 25 – 50 % reduction in liver size and a 100% frequency of persistent 
ductus venosus, a fetal portocaval shunt from the portal vein to the inferior vena 
cava that normally closes at birth 125. For their first weeks of life, their growth rate is 
retarded compared to wild-type controls 75, 119. At adulthood and during aging, these 
animals exhibit cardiohypertrophy, hyperplasias of glandular mucosa and the 
forestomach stratified squamous epithelia, and hyperkeratosis and marked dermal 
fibrosis 121. AHR-/- mice are susceptible to bacterial-related inflammation since they 
exhibit defects in T cell differentiation 139-141.  
There are rather recent studies supporting the role of AHR in intermediary 
metabolism: Wang and coworkers reported that AHR-deficient mice tended to have 
lower blood glucose (throughout the day) than wild-type mice, and AHR deficiency 
improved glucose tolerance and insulin sensitivity as compared with normal 
C57BL/6J mice 142. Furthermore, there are reports that AHR also may have a role in 
fatty acid metabolism and synthesis, as well as in lipid transport 143-145.  
2.3 Overview of some issues affecting energy homeostasis 
and food intake behaviour 
During evolution it has been beneficial for the survival to synchronise energy intake 
and consumption i.e. balancing anabolic and catabolic processes throughout the day 
(circadian rhythm): adjust physiology and behaviour efficiently in such a way that a 
function is optimal for the occurrence (linking external cues from the environment to 
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the individual needs, such as food availability and energy intake in conjunction with 
the activation of metabolism and induction of xenobiotic enzymes). Sufficient time 
is needed for both metabolic activities and resting (internal processes). Highly 
conserved and complex adaptive mechanisms defend the lower limits of adiposity 
and maintain appropriate energy and water balance. In the optimal situation, this 
regulation guarantees adequate intake for the basic physiological and biochemical 
processes involved in metabolism, in thermogenesis, in skeletal muscle action, as 
well as in growth and reproduction. Impaired regulation leads to diseases, for 
example obesity, metabolic disorders, or anorexia. Furthermore, because both 
human beings and animals consume food within meals, the factors affecting 
individual meal size, duration, and their appearance are important determinants of 
total daily food intake 13, 146.  
This is an area of intense research activity: a literature search for ‘food intake’ 
identifies each year hundreds of published review articles, a trend which has 
continued over the past years. Since this is such a broad field of science, Chapter 2.3 
provides an overview of some issues contributing to energy homeostasis, especially 
to feeding behaviour, the issues most relevant to this thesis.  
2.3.1 Meal regulation and the control of energy balance 
The primary peripheral players of energy balance are the gustatory system and GI-
tract, pancreas, liver, muscle and adipose tissue. GI-tract offers space for digestion 
and absorption processes which are optimised by the direct actions of gut hormones. 
Since the sensations of hunger and satiety are orchestrated in the brain the control of 
energy homeostasis requires bidirectional, integrated signaling between brain and 
periphery either through direct neural connections or via blood 15, 16. Already in the 
1950’s Gordon Kennedy proposed that the brain monitors body weight and adiposity 
which are defended against challenges to maintain a constant level, ‘set-point’ – also 
called the lipostatic hypothesis 147, 148.  
Control of meal taking consists of within-meal related signals (satiation) as well 
as meal-to-meal, between meal related signals (satiety). These feeding-related terms 
are often collectively called ‘satiety signals’, although this term neglects the 
important difference between the terms satiation and satiety. Hunger drives meal 
initiation, but there many other contributing factors affecting satiety and the time 
between meals. These include factors like hedonic value of food, learning, 
appearance of food, and social circumstances – factors which are more dependent on 
other cues rather than the energy status of the body. Although they are known to be 
important contributors to energy balance (especially in humans) their regulatory 
mechanisms are not as well known as those controlling satiation, individual meal 
size and its termination.  
Meal taking is under the direct, short-term control of various sensory signals and 
hormones related to the satiation process during ingestion of food. An important 
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location for these signals in the bidirectional pathway between the brain and 
periphery is the nucleus tractus solitarius (NTS) in the hindbrain (Figure 5). The 
hindbrain is also responsible for the motor coordination of ingestion. However, 
meals are also affected by other factors such as levels of circulating nutrients, 
correlates of stored energy (adiposity signals leptin and insulin), rhythmic factors 
(e.g. estrous cycle), and cues from the ambient environment (such as temperature or 
seasonal changes). These factors may be considered as indirect factors regulating 
energy balance 149. Figure 4 represents the primary regulatory sites and pathways of 
the regulation of energy balance and feeding. 
2.3.1.1 Taste pathways and role of tasting system in food intake  
The understanding of taste mechanisms has increased enormously following the 
identification and cloning of the taste receptor genes (for a review, see 155). Flavour 
and somatosensory sensations have their own pathways differing from the tasting 
system, including the gustatory signals that originate from the epithelial cells of the 
taste buds (triggered by water-soluble compounds), the olfactory signals that 
originate from the epithelial cells in the nasal cavity (triggered by volatile 
compounds), and the somatosensory signals that activate ion channels in the 
somatosensory nerve fibers (such as capsaicin) 156. In mammals, nutrients are sensed 
in the oral cavity and in the GI-tract (Figure 4), with the mechanisms being currently 
most well-known for the sweet, amino acid (umami) and bitter. They are detected by 
the family of G-protein coupled taste receptor families (T1Rs for sweet and amino 
acid, T2Rs for bitter). In short, gustatory stimuli – sweet, bitter or umami – excite 
taste buds leading to adenosine triphosphate (ATP) release from the receptor cells 
that downstream stimulate afferent nerves and presynaptic cells leading to 
neurotransmitter (serotonin and/or noradrenaline) release. For sour and salty 
compounds, the tasting mechanism involves ion channels the former being sensitive 
to the H+ ion (acids) and the latter to Na+ ion (reviewed in 156-158). The status of the 
fat taste receptor is still a topic of debate but apparently fatty acid detection involves 
many different mechanisms, including inhibition of K+ channels in taste cells, 
activation of fatty-acid transporters (e.g. CD36), and specific G-protein coupled 
receptors. Fatty acids act via these receptors and they have been shown to trigger an 
increase in intracellular calcium concentrations that in turn stimulates the release of 
numerous neurotransmitters and gut hormones 159.  
Taste pathway from the tongue and mouth (Figures 4 & 5) reaches rostral part of 
the nucleus tractus solitarius (NTS) through cranial nerves from where the pathway 
projects to the parabrachial nucleus (PBN). In addition, taste receptors in taste 
receptor cells are also found in the intestine and from there an important route for 
visceral sensory signals to the brain is the vagus nerve, another route being via 
bloodstream through area postrema (AP) in the caudal brainstem. These visceral 
pathways converge at the caudal part of NTS to project to PBN. Gustatory neurons 
of PBN project to the forebrain either via thalamocortical pathway [thalamus – 
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insular cortex (IC)] or via lateral hypothalamus (LH, or lateral hypothalamic area, 
LHA) and bed nucleus of stria terminalis to specific regions of amygdala, where 
there are partly reciprocal connections to the responsive sites of the brain 16, 150, 154.  
2.3.1.2  Some integrators participating in the regulation of energy balance 
Vagal stretch and tension sensors that work in harmony with mechanosensitive 
transducers and neurotrophic factors mediate information about the stomach fullness 
and nutrients within the GI-tract. Thus, they play a role at least in meal regulation 
and presumably they also contribute to long-term energy balance. It seems that vagal 
sensory activity and its modulation by regulatory peptides (see below) participates 
also in the control of meal frequency and in the initiation of a new meal 150.  
Enteroendocrine cells in the gastrointestinal epithelium release hormones in 
response to nutrient stimuli. For a schematic drawing of the regulatory pathways, see 
Figure 4. In addition to communicating with each other, feeding regulatory peptides 
have modulatory effects in the brain 160. Cholecystokinin (CCK) suppresses feeding 
by acting on receptors of vagal nerve terminals in the mucosal lamina propria 151. 
Peptide YY (PYY) and glucagon-like-peptide (GLP-1) are intestinal peptides 
mediating their anorectic effects on brain via vagus-brainstem pathway, although 
also other mechanisms are at play. PYY acts as a direct anorexigen via neuropeptide 
Y2 (NPY2) receptors in the hypothalamus, whereas GLP-1 acts there on its own 
receptors. All the previous peptides inhibit also gastric emptying 161. Furthermore, 
GLP-1 acts on pancreas to stimulate insulin and inhibit glucagon release i.e. it is an 
effective regulator of glycemic balance. GLP-1 is shown to have an acute 
diminishing effect on the ongoing meal, leaving the intermeal interval and 
subsequent meal sizes intact 162. GLP-1 is one of the site-specific cleavage products 
of proglucagon, the others being intestinal oxyntomodulin (OXM) and pancreatic 
glucagon. In addition to diminishing meal size, OXM may participate in the control 
of energy expenditure, along with glucagon. Glucagon regulates blood glucose level 
affecting the mobilisation of glucose and stimulating hepatic gluconeogenesis; it 
also reduces meal size 163, 164. 
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Figure 4 (Continued). Schematic drawing shows the complicity of the regulatory pathways. 
In the figure there are shown primary regulatory sites and mechanistic pathways for the 
detection of eaten food and nutrients. Figure is modified from 150, according to 14, 16, 151-
154. Abbreviations: α-Gust=α-gustducin; AA transp.=amino acid transporter; AP=area 
postrema; BBB=blood-brain barrier; CaR=calcium receptor; CCK=cholecystokinin; 
CCK1R=receptor for cholecystokinin; 5-HT=serotonin; 5HT3R=serotonin receptor; 
CD36=fatty acid binding-protein; FATP4=fatty acid transporter protein; GHSR=G-protein 
coupled growth-hormone-secretagog receptor (ghrelin receptor); GLP-1=glucagon-like 
peptide-1; GLP-1R=receptor for glucagon-like peptide-1; GLUT2=glucose transporter 2; 
GPCR6A=G-protein coupled receptor-6, amino acid sensing receptor; GPR120=fatty 
acid-binding G-protein coupled receptor; NT=neurotensin; NTS=nucleus tractus solitarius; 
OXM=oxyntomodulin; PBN=parabrachial nucleus; PLCβ2=phospholipase β2; 
PP=pancreatic polypeptide; PYY=peptide YY; SCN=suprachiasmatic nucleus; 
SGLT1=sodium glucose co-transporter; T1Rs=taste receptor 1 family members; 
T2Rs=taste receptor 2 family members; TRPM5=taste selective cation channel; Y2R= 
receptor for PYY, neuropeptide Y2 receptor. 
The only known hunger signal is ghrelin, a hormone excreted by the oxyntic 
X/A-like cells in the gastric mucosa of the empty stomach (differing from other 
peptides which are released postprandially) 165, 166 and by specific neurons in the 
hypothalamus 167. Its effects are mediated via vagal afferents and bloodstream 168. 
Other intestinal peptides involved in meal control include obestatin, neurotensin 
(NT), glucose-dependent insulinotropic polypeptide (GIP), and vasoactive 
instestinal peptide (VIP) together with pancreatic peptides amylin and pancreatic 
polypeptide 161, 169. For example, pancreatic amylin and pancreatic polypeptide are 
anorectic by promoting meal termination, diminishing meal size 170.    
The presence of glucose in the intestine can be signalled to the brain via many 
routes. The blood glucose level is an indicator of the nutritional state, and a transient 
decline is related to meal initiation 171, 172. In the periphery, the hepatic portal vein 
and pancreatic β-cells are innervated by vagal afferent fibers which have the ability 
to sense blood glucose levels 150. Furthermore, the blood glucose concentration is 
sensed in the intestine through gluco- and osmoreceptors, and in the CNS via many 
neural pathways. In addition, nutrients are known to be able to modulate energy and 
glucose balance also by acting directly on the brain. Sweet taste receptors are 
expressed within the brain 173 and some hypothalamic neurons appear to be 
glucosensitive, being able to adjust their firing rate according to the extracellular 
glucose concentration. In addition, fatty acids can act as cellular messengers within 
brain, informing fatty acid sensitive neurons about the energy status. It seems that 
glucose and fatty acid sensing neurons show inverse responsiveness depending on 
metabolic signals, and thereby these neurons contribute to energy balance by 
adjusting feeding behaviour, hepatic glucose production or insulin secretion 
accordingly (reviewed in 174, 175). For example, increase in FFA level induce 
anorectic signalling within CNS 174.    
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 Currently, leptin and insulin are considered to serve as key circulating signals of 
body energy stores and adiposity. They exert short- and long-term effects on 
metabolic balance in the brain and periphery including direct effects on intermediary 
metabolism, feeding, and thermogenesis. Insulin regulates blood glucose levels (e.g. 
by facilitating glucose transport into muscle and adipose cells, and by promoting 
protein and lipid synthesis) and it sends information of body adiposity to the CNS 
along with leptin, a peptide secreted by white adipose tissue 176, 177. Adipose tissue is 
an important and active metabolic organ, releasing many regulatory messengers: 
leptin, adiponectin, resistin, and many growth factors and cytokines. Furthermore, 
adipocytes produce angiogenic factors which are involved in neovascularisation of 
adipose tissue, thus body adiposity is controlled also by that means 178, 179. While 
insulin and leptin are synthetised in the brain only in small amounts (if at all), they 
are transported into the brain by a saturable transport system via the blood-brain 
barrier (BBB), thus the transport system modulates leptin and insulin action 180. 
When inside the brain, they are both able to induce direct neural effects via receptors 
in neural cells 181, 182. In experimental models, if either leptin or insulin effects are 
blocked in the brain the outcome is increased food intake and adiposity 177, 183. In 
obesity, hypothalamic and peripheral resistance develops to both of these hormones 
184, 185. NTS appears to be a very important relay station for the actions of leptin. 
There are leptin responsive neurons within NTS, and ascending pathways from the 
periphery to the brain and descending projections from the leptin-activated 
hypothalamic neurons pass through the NTS 149.     
The hypothalamus in concert with endocrine organs (pituitary, thyroid and 
adrenal glands) has an important role in the maintenance and control of basal 
metabolism and thermogenesis. The pituitary gland which is under the control of 
hypothalamic neurons synthetises and releases various endocrine hormones (e.g. 
somatotropin or growth hormone, thyroid- and melanocyte-stimulating hormones, 
gonadotropins, corticotropins, oxytocin and antidiuretic hormone) that affect directly 
energy and water balance and regulate gene transcription throughout the body. 
Together with the hypothalamus and the thyroid, the pituitary gland controls hunger, 
thirst, temperature, and behaviour according to the environmental and metabolic 
cues (Figure 5). One needs a balance between the hypothalamus, pituitary and 
adrenal system in order to keep endocrine system functional and this involves many 
regulatory feedback loops, including direct and indirect neural pathways (e.g. 
reviewed in 186, 187).  
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Figure 5. Schematic drawing of neural areas and numerous factors that affect 
regulation of eating, taste processes, and energy balance. Various inputs 
and outputs (outputs encircled) are written with capitalised letters, and 
arrows indicate an approximate site that is responsible for the control. 
Modified from 188, according to 14, 160, 177, 189, 190. Abbreviations: Am, 
Amygdala; AP, Area postrema; ARC, Nucleus Arcuatus; LHA, Lateral 
hypothalamic area; NAcc, Nucleus accumbens; NTS, Nucleus tractus 
solitarius; PBN, Parabrachial nucleus; PVN, Paraventricular nucleus; 
SCN, Suprachiasmatic nucleus; SN, Substantia nigra; VMH, Ventromedial 
hypothalamic nucleus; VTA, Ventral tegmental area. 
2.3.2 Behavioural aspects of feeding and drinking: conditioned taste 
aversion and neophobia with their neural substrates  
Gustatory neophobia and taste memory in mammals play a role in survival: when a 
novel food is offered, neophobia prevents an animal from eating until the food 
appears to be safe 191. Rodents are opportunistic omnivores and unable to vomit. 
Therefore they display especially strong neophobic responses when a novel, and 
potentially harmful, food item is offered. There are two behavioural phenomena that 
prevent an animal eating potentially harmful, toxic food item: the first is the 
neophobia, an innate organised and adaptive behaviour, and the second is 
conditioned taste aversion (CTA), a learned behaviour that prevents consumption of 
a food previously provoking gastrointestinal discomfort 192. In experimental settings, 
the consistency of the aversive effect depends on novel food item properties 
(olfaction, taste, nutritive value) and on the social facilitation between individuals (if 
possible). In addition, the gender and age, as well as the experimental conditions 
may affect the outcome. Food restriction, and additional odours, flavours, visual or 
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auditory cues coupled with a conditioned stimulus (CS) may potentiate the aversion 
193-198. In addition, taste-recognition memory has a key role: the animal needs to 
remember the consequences of comsumption and be able to associate either the 
familiarity or the spatio-temporal relation between illness and food/drink intake 
during the second encounter 154.  
Increasing diet variability enhances fitness and therefore it is evolutionarily 
beneficial to taste new food. New foods are sampled and if a postingestive malaise 
does not follow within a few hours then neophobia dissipates and food intake 
increases rapidly 199. That novel stimulus becomes familiar and neophobia is 
attenuated demands associative learning i.e. learning that there is no malaise linked 
with the taste. This is termed as appetitive memory 154, 200, 201. 
If malaise does occur, then the taste becomes an aversive signal, resulting in 
aversive avoidance behaviour. CTA can be recognised in various animal species 
from reptiles to mammals, including humans. For example, in humans, CTA is one 
of the adverse side effects encountered in cancer therapy (reviewed in 191). 
Experimentally, taste can be considered as a CS and the resulting digestive illness as 
an unconditioned stimulus (US). Most typically, lithium chloride is used as an US to 
produce gastrointestinal illness. Differing from the other types of condititioning (a 
phenomenom that was first characterised by the Russian physiologist Ivan Pavlov 
around the turn of the 20th century), taste aversion in rats may occur even if there is a 
long time lag (up to 12 hours) between CS and US while a very short (minutes or 
seconds) interval may not result in CTA 202, 203. That evidences the need for certain 
post-ingestive period, the time for the stimulus to be detected and the memory to be 
formed (from minutes up to several hours). In this process, the orosensory properties 
of food (CS) are involved, affecting also gastrointestinal chemoreceptors which 
potentiate CTA response 196, 204. A positive stimulus can also be used in 
conditioning, for example to test flavour-nutrient learning 205. The learned CTA 
response diminishes if CS is presented without US: a phenomenom called extinction 
in Pavlovian terms.  
Many experimental manipulations during US presentation (such as anaesthesia or 
sleep deprivation) have proved ineffective in preventing the formation of CTA, 
whereas they do disrupt or modify attenuation of neophobia 206-209. These findings 
indicate that there are two different neural mechanisms both for appetitive and 
aversive memory acquisition and consolidation. At an early stage, taste recognition 
is similar for both phenomena, using the pathways described in Chapter 2.3.1.1. 
Then, depending on the gastrointestinal consequences, the different pathways and 
memory processes come into play 210. Finally, in both aversive and appetitive taste 
learning processes, long-term memories need to be formed and long-term 
potentiation together with plastic changes in neural functions are needed. Thus, 
activation of genes, protein synthesis, and synaptic arrangements are required for 
memory formation, consolidation and extinction 211, 212. The entire process from 
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novel food item presentation leading finally to its consumption involves many 
complex pathways, of which the main regulatory networks will be described below.  
NTS and PBN are important relay locations for both the taste and for the visceral 
sensory signals. Both areas display region specific activity depending on the novel 
taste stimulus 213-216. In addition, neurons in the nucleus accumbens (NAcc) detect 
novel taste by decreasing their spontaneous activity, and subsequent changes in 
dopaminergic, glutamatergic and cholinergic activity follow (reviewed in 200, 201). 
Cholinergic system of the basal forebrain including nucleus basalis magnocellularis 
(NBM) has innervations to the cortical mantle, hippocampus and amygdala, which 
are important areas in safe memory processes. NBM modulates acetylcholine (ACh) 
release that increases in response to novelty, to gustatory stimuli and during 
appetitive conditioning. It has been shown that increased Ach release in NAcc shell 
occurs if the novel food produces malaise, but not if the food appears to be safe 200, 
217. Thus, cholinergic system participates in the recognition and in the categorisation 
of novel stimuli 154.   
PBN is an important location for the aversive taste memory (for the location in 
the brain, see Figure 5), since it is the site where signals of visceral malaise and taste 
signals interact. PBN receives glutamatergic projections from the NTS, and 
glutamatergic activity via metabotropic receptors in the PBN seems necessary for 
the association between aversive taste and gastric malaise 218, 219. Hence, cholinergic 
and glutamatergic systems act synergistically since cholinergic activity is needed for 
the novel taste recognition and glutamate participates in transforming the safe taste 
into an aversive one. An aversive stimulus increases cholinergic activity in IC, but 
also glutamatergic N-methyl-D-aspartate (NMDA) receptors in the NAcc are 
believed to be involved in aversive memory processing, in the interplay with IC and 
basolateral amygdala. In addition, dopaminergic activity (modulated by the taste and 
visceral inputs innervating the PBN) in the NAcc participates in taste encoding and 
taste memory formation (reviewed in 200, 201, 220).  
The areas of importance in consolidation of aversive memories and in the 
formation of long-term taste memories are IC and amygdala, especially the central 
nucleus of amygdala (CeA), and the basolateral amygdala, that receive visceral 
signals from PBN. In IC, CeA, and basolateral amygdala glutamatergic system is 
intimately involved in CTA memory processing 221-224. IC receives also ascending 
taste information from thalamus. Other cortical areas, e.g. perirhinal, entorhinal and 
medial prefrontal cortices participate in the formation of taste memories, and are 
interconnected with many taste processing areas 201. Moreover, these systems are 
modulated by neurotransmitters and neuropeptides 211, 225. Previously taste memory 
formation was not believed to involve any major interplay of hippocampus with 
cortical structures, but more recent studies argue that hippocampus may have a role 
in the specific modulation of taste memory 226, 227. In addition, De la Cruz and 
coworkers showed that protein synthesis in the hippocampal and cortical (perirhinal 
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and insular) areas is required for the safe taste memory consolidation as well as for 
the attenuation of neophobia 228. 
Although behavioural reponses have been reported to occur even after several 
months, the offering of CS without US leads to extinction, a process which requires 
dynamic activity changes in distinct brain areas 229, 230. There are several studies 
demonstrating that extinction is not associated with forgetting – unlearning the 
original association with malaise (US) and taste stimulus (CS) – but instead it 
involves learning of a new association that competes with the original one (reviewed 
in 191). If the malaise-inducing agent remains absent, it seems that the appetitive 
memory trace strengthens, and it has been shown that IC has also an important role 
in extinction processes. However, it has been claimed that CTA consolidation and 
consolidation of CTA extinction appear to be two different memory processes, and 
both require newly synthetised proteins 228, 231, 232.  
2.3.3 Circadian rhythmicity  
Circadian rhythms constitute an important regulatory network for optimal 
physiological and behavioural adaptation into an ambient environment. At the 
molecular level structurally similar circadian oscillators can be found in the brain 
and in peripheral organs, and they actively synchronise behavioural activities and 
rhythms of hormone secretion, temperature, blood pressure, metabolism, and sleep-
wakefullness with environmental cycles 233, 234.  
The master clock was found already in the early 1970’s, the suprachiasmatic 
nucleus (SCN) in the hypothalamus (Figure 5) 235, 236, where heterogenous circadian 
clock cells generate circadian rhythms involving clock genes and their protein 
products. Most important are the positive regulators brain and muscle ARNT-like 
protein 1 (BMAL1) and Circadian locomotor output cycles kaput (CLOCK), and 
repressors Period1 and 2 (Per1 and 2), Cryptochrome1 and 2 (Cry1 and Cry2). In 
short, this evolutionarily conserved regulation functions as follows: BMAL1 and 
CLOCK proteins dimerize in the cytoplasm, translocate in the nucleus, and bind to 
cis-regulatory element (E-box) sequences of repressor genes to activate their 
transcription. The protein products of the repressors inhibit the activity of Bmal1 and 
CLOCK, thus generating a negative feedback loop for their own transcription. 
However, it should be borne in mind that the control of circadian rhythmicity is 
controlled by the transcription and translation of numerous other genes; altogether 
approximately 600 genes are expressed in a rhythmic manner within SCN 237-240. 
Information from the retinal ganglion cells uses direct retinohypothalamic track 
to entrain suprachiasmatic neurons to light-dark cycles. Additonal afferent systems 
to SCN include geniculohypothalamic track and the brainstem serotonergic system. 
These pathways use many classical neurotransmitters in their signalling [e.g. 
excitatory glutamate and inhibitory gamma-aminobutyric acid (GABA), 
neuropeptide-Y (NPY), acetylcholine, and histamine]. Via its many efferent 
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pathways, the SCN entrains the rhythmicity on neural systems, on peripheral organs 
(which similarly to SCN, express clock genes and have a high number of 
rhythmically regulated genes), and on endocrine and immune functions 240-243. 
Although SCN is the master clock, many other systems are able to maintain 
molecular clockwork even without the control of the SCN 240, 244, 245. One example 
of that is the food-entrainable system 246.  
A food-entrainable circadian pacemaker is located (still at an unknown location) 
outside of the SCN, as SCN-lesioned animals or animals with disturbances in SCN-
generated rhythms are able to generate a feeding related circadian rhythm 247, 248. 
Feeding and fasting entrain rhythms in peripheral organs and in extra-SCN areas in 
the brain (food-anticipatory rhythms), whereas the SCN clock has been considered 
impervious to feeding cues, especially if the photic stimulus is present. Nevertheless, 
it has been shown that timed availability of food and macronutrients, especially if 
associated with hypocaloric conditions, lead to phase-changes in SCN-controlled 
rhythms and also in the SCN clock 249-251, possibly due to a hypometabolic state 252. 
Furthermore, increasing evidence exists nowadays that various metabolic cues are 
linked to circadian rhythmicity, constituting a bidirectional loop between peripheral 
metabolism and SCN 253, 254. In other words, nutritional inputs and peripheral clock 
signals can alter signaling pathways and rhythmicity in the brain, while the circadian 
rhythmicity of circulating hormones (e.g. insulin) is modulated by the SCN. 
Currently there is ample evidence showing how the metabolic state can affect the 
circadian clockwork. A typical example is the interplay between sirtuin1 (SIRT1), 
clock genes (BMAL1 and Per2) and nicotinamide adenine dinucleotide (NAD+). 
SIRT1 is a NAD+ dependent mitochondrial deacetylating enzyme involved in 
transcriptional silencing, genome stability, and longevity, whereas NAD+ functions 
as an indicator of the cellular metabolic state. SIRT1 is known to deacetylate 
BMAL1 255 and Per2 256, thus it participates in the circadian clockwork by regulating 
clock gene expression. As the enzymatic activity of SIRT1 is regulated by its 
coenzyme NAD+ 257, and there is a report that adenosine monophosphate -activated 
protein kinase (AMPK) is involved in enhancing SIRT1 activity by increasing 
NAD+ 258, the cellular metabolic state has a crucial modulatory potential for 
regulating rhythms. There are many other players involved in the coupling of 
circadian clockwork to metabolic cycles, e.g. glucose sensors and many nuclear 
receptors (reviewed in 234, 254, 259).   
In addition to light and feeding rhythm, sleep deprivation, aging, high-fat diet, 
pharmacologic agents in rodents, even availability of a running wheel can alter the 
circadian oscillation of molecular clockwork and vice versa. These changes can be 
detected as alterations both in behaviour and in gene and protein expression. The 
motivational value of food has also many entraining properties on the regulatory 
pathways, even though these effects are modified by species and gender-related 
factors, as well as the composition of offered meal 244, 260-263. In this context the use 
of pair-fed control animals (feed-restricted in TCDD experiments: given food 
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relative to that consumed by exposed animals) should be mentioned. Pair-feeding is 
a useful way to compare the effects of altered feeding per se to those of the 
compound being studied 17. Nevertheless, similar daily energy consumption does not 
necessarily determine factors like adiposity or body weight level (e.g. 264-266). It was 
shown by Pohjanvirta 267 that the signalling pathways activated by feeding cues do 
not remain similar during a period of restricted feeding. Similar weight-loss but 
different durations of feed restriction caused entrainment of peripheral oscillator 
genes and disturbances in circadian rhythms. Since the pair-feeding usually occurs 
during the daytime – at the time of lowest feeding in the case of many rat strains – it 
apparently modifies many feeding related outcomes and metabolic cycles in 
different ways, if one compares pair-fed animals to their ad libitum fed counterparts 
and study subjects. It has been shown that a timed offering of a palatable food item 
in a remarkable amount (relative to daily energy intake), even without food 
restriction, can entrain various aspects of circadian rhythmicity. Not only the 
behaviour 268, 269 can be modulated but also gene expression in brain and in 
peripheral tissues 245, 269-271. Provision of a hypercaloric, high-fat diet appears to 
dampen diurnal rhythmicity of feeding and metabolism 264, conversely, the 
contrasting situation: severe feed restriction has been shown to lead to phase-
advances, as already mentioned. However, phase-advances have been found in many 
endpoints such as in body temperature, hormone levels, molecular pathways and in 
many kinds of behaviours. After extended periods on a hypocaloric state nocturnal 
animals have become somewhat diurnal (reviewed in 245).   
2.4 Effects of dioxins on energy homeostasis and feeding 
behaviour 
2.4.1 Wasting syndrome  
The feeding related effects of dioxins are rather atypical manifestations of 
chemicals. The wasting syndrome as an outcome of dioxin exposure is typified by a 
dramatic reduction in feeding and the corresponding decline in body weight in 
exposed animals 272. Lethality is delayed, but if the dose is high enough (bearing in 
mind that the lethal dose varies tremendously between animals) animals refuse to eat 
and they lose as much as 50 % of their body weight before they succumb within 1 – 
8 weeks 3, 273. At doses higher than the lethal dose, the time to the death is not 
markedly affected by the dose, but usually exposed animals do not show total 
feeding refusal - feeding declines progressively. At sublethal doses permanently 
stunted growth, decreased feeding, and alterations in feeding behaviour occur 
(reviewed in 3, 4, 10). Furthermore, at sublethal doses after 1 – 2 weeks (depending on 
the dose and the animal) feeding is enhanced and there is subsequent weight gain. 
Nevertheless, exposed animals seem to maintain body weight at a lower level in 
comparison to their controls. The weights of the treated animals stabilise 
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permanently to a lower level, which has been termed the ‘lowered body weight set-
point’ due to exposure. There are several results supporting the lowered body weight 
set-point, e.g. TCDD-exposed rats are able to defend their lowered body weight 
level against various feeding challenges, and they are able to gain weight or to 
increase feed intake after fasting 273-277. The body weight set-point hypothesis was 
tested with streptozotocin-induced diabetic rats (animals which are hyperphagic and 
underweight), even after TCDD treatment diabetic H/W rats remained hyperphagic 
relative to their non-diabetic counterparts. Feed intake and weight gain were only 
mildly affected by TCDD as compared to the situation in diabetic rats. Although 
insulin abolished the body weight loss in both groups, the TCDD-group stabilised 
weight to the level of TCDD-treated non-diabetic rats 278. These findings reveal that 
hypophagia as such is a tool for adjusting the body weight level in response to 
TCDD. 
There are studies revealing that animals do not suffer from nausea 279, and neither 
gross malabsorption nor increased energy expenditure offer explanatory roles in 
wasting 273, 277, 280. Hypophagia and thereby depleted energy stores could be regarded 
as the cause of death following dioxin exposure: approximately at that time also the 
pair-fed controls died because of the reduced energy intake 281, 282. Nevertheless, 
these findings do not provide a full explanation for the lethality, and other 
mechanisms are also at play. This is supported by the findings that force feeding 
cannot prevent the death of TCDD-treated animals; this has been demonstrated in 
rats 283, 284 and in guinea pigs 285. Furthermore, dietary modulation of TCDD-induced 
wasting proved ineffective, as neither obesity nor high-energy diet could prevent 
weight loss in the resistant H/W rats. Provision of a balanced liquid feed prevented 
the weight loss in L-E males while a high-fat diet seemed to be related to shortened 
life-span in TCDD-treated L-E female rats 284. In general, fat has appeared to be the 
only macronutrient that is an unfavourable energy source after exposure to TCDD in 
rats 12, 286. In contrast, in one study in female mice (harbouring a high-affinity AHR 
for TCDD, LD50 value was not given) the consumption of a high-fat diet combined 
with TCDD treatment resulted in a significantly accelerated body weight gain at the 
highest dose (100 µg/kg i.p.) tested, while the lower doses (1 or 10 µg/kg) were 
ineffective, with or without the high-fat diet supplement 287.  
The group of Rozman has examined whether TCDD can affect brown adipose 
tissue and induce thermogenesis (see below). Brown adipose tissue cells contain 
several small droplets of fats, and these cells are loaded with mitochondria capable 
of generating ATP. Additionally, there is also proton conductance that causes 
uncoupling of oxidative phosphorylation from the generation of ATP, leading to the 
generation of heat, known as nonshivering thermogenesis. Fat cells and blood 
vessels within brown adipose tissue have a sympathetic innervation, thus enhanced 
sympathetic activity may induce lipolysis and heat production, and loss of energy 
288. At sublethal and lethal doses, TCDD has been reported to evoke morphological 
alterations in the interscapular brown adipose tissue 289, 290: the number of lipid 
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droplets in brown adipose tissue diminished and their size was enlarged, followed by 
progressive lipid depletion. However, no activation of thermogenesis as a 
consequence of exposure was reported; on the contrary, exposed rats appeared to be 
hyposensitive to noradrenaline-induced thermogenesis in brown adipose tissue 291.    
Factors related to stress responses or direct stomach effects vary, and do not 
explain wasting. TCDD has been shown to decrease gastric emptying and gastric 
acid secretion, but there was no evidence of hypoplasia of the acid-secreting parietal 
cells in the stomach 292. Gastrointestinal hemorrhages following exposure appeared 
to be related to problems in blood clotting due to impaired hepatic production of 
coagulation factors 293, 294. Stress factors from the hypothalamus-pituitary-adrenal 
axis exhibit varying responses to TCDD depending on the dose, animal, and other 
experimental settings (reviewed in 3, 10). For example, in H/W rats and L-E rats 
plasma corticosterone levels did not change at all, or there was an insignificant 
increase in response to TCDD, respectively 295.  
The liver is the target organ of TCDD and low doses induce many hepatic 
enzymes, a reversible response relative to tissue concentration of TCDD. At 
relatively high doses, liver hyperplasia and necrosis occur in many species. Liver 
toxicity is associated with impaired biliary clearance, degenerative changes and 
oxidative stress (reviewed e.g. in 3, 4). During the wasting process, body fat stores 
are mobilised, fat synthesis as well as several lipogenic enzyme activities decline 
and fat infiltrates into the liver 286, 296, 297. In rats, the serum free fatty acid (FFA) 
levels increase, and the disturbed lipid metabolism causes also enhanced levels of 
serum triglycerides and cholesterol. According to the results from many animal 
studies, TCDD can induce specific time- and dose-responsive effects on glucose and 
fat metabolism, e.g. on cholesterol biosynthesis, and fatty acid synthesis and 
oxidation. These effects have been most extensively studied in liver tissue, and can 
be observed in many species also at low doses (e.g. 45, 91, 298, 299). 
The effects of dioxin on adipose tissue include insulin-resistance like symptoms: 
downregulation of insulin receptors and glucose transporters, and a subsequent 
suppression of insulin-stimulated glucose uptake in vivo and in vitro 300-302. Serum 
insulin levels decrease, apparently due to hypophagia and the body weight loss at 
high dose that causes also a reduction in blood glucose levels 303, 304. However, 
blood insulin 305 and glucose levels decrease also at sublethal levels, and the 
inhibition of gluconeogenetic enzymes may contribute to lowering of the blood 
glucose concentration, namely the inhibition of the key enzyme, 
phosphoenolpyruvate carboxykinase (PEPCK) 306, 307. TCDD was shown to relieve 
hyperglycemia encountered in high-fat fed and streptozotocin induced diabetic rats 
308. In the glucose tolerance test, blood glucose levels were similar in TCDD-treated 
mice and their controls although controls had higher insulin levels 309. After TCDD 
exposure, rats became hypersensitive to insulin-induced hypoglycemia 274, 304, 310. 
Thus, although exposure has been shown to impair pancreatic insulin secretion in 
vivo, in vitro and ex vivo 309, 311, administration of TCDD seems to enhance insulin 
Review of the literature 
 
THL — Research 146 • 2014 47 
No Chocolate, Please! Dioxin-induced 
Responses in Feeding Related 
Behaviour and in Neuronal Activity 
 
function and sensitivity in animals. In this context it should be noted that continuous 
exposure and thus the elevated body burden of dioxin-like compounds in humans 
has been linked to induction of type II diabetes 312. In contrast to the situation in 
rodents, in humans exposure seems to increase blood glucose and insulin, and to 
enhance insulin resistance 313-315. Apparently this issue warrants more research as 
there are also studies which have detected no association between human diabetes 
and TCDD 316, 317.  
2.4.2 Alterations in circadian rhythms - possible role of AHR in the 
regulation? 
A wide variety of physiological functions display circadian rhythms (Chapter 2.3.3), 
e.g. most aspects of xenobiotic metabolism are under the control of circadian 
regulation. Although the metabolism has its own regulatory component being 
activated by xenobiotics, detoxifying enzymes do show expression patterns in a 
circadian fashion. The oscillation of proteins and their encoding mRNAs may have 
different characteristics, but in recent years emphasis is given for the fact that the 
fluctuations can affect drug efficacy and/or toxicity throughout the day 233, 234. On 
the other hand, many xenobiotic compounds can perturb the regulation of circadian 
rhythms by affecting circadian genes or via interactions with metabolic proteins. 
Furthermore, bearing in mind that food is one of the important peripheral circadian 
timekeepers (Chapter 2.3.3), exogenous compounds capable of altering feeding 
behaviour may also entrain circadian rhythmicity by that means.   
TCDD exposure has been shown to alter circadian feeding rhythms in various rat 
strains. After H/W rats have reached their lowered body weight (about 2 weeks 
following high TCDD dose) they shift their feeding to the daytime, i.e. their food 
and water consumption is mainly unaffected during daytime in comparison to 
darkness. This effect remained for months in resistant H/W rats 274, 275, and similar 
kinds of responses have been found in L-E 318 and Sprague-Dawley rats 281. Studies 
with mice also revealed altered circadian rhythmicity, with a high dose level of 
TCDD causing phase advances in locomotor activity (319, 320, congress abstracts). 
Circadian expression of various hormones is affected by TCDD, exemplified by 
corticosterone which was rendered without any rhythm 321, or melatonin whose peak 
levels were suppressed after TCDD 322, 323. In addition to TCDD, other activators of 
the AHR are capable of altering feeding behaviour. For example nicotine, an inducer 
of CYP1A enzymes 114, has been shown to flatten circadian peaks in feeding and to 
diminish eating by decreasing both meal size and meal numbers in rats 324.  
While the role of AHR in the circadian rhythm regulation without a bound 
exogenous ligand is still a target for intensive studies, several other proteins 
belonging to the same PAS family, such as BMAL1 (referred also ARNT3 due to 
structural similarity to ARNT) and CLOCK, are key regulators of the circadian 
rhythms 325-327. The expressions of PAS proteins (including AHR) and their 
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encoding mRNAs fluctuate during the day in several mouse and rat tissues 90, 328. On 
a normal light/dark rhythm, the peak in Ahr transcripts occurs during the time of 
lights off in SCN, and in liver 4 hrs earlier 329. PAS proteins have revealed the tight 
interplay in AHR-mediated responses in the presence of an agonist 330-332, for 
example in mice TCDD disrupted rhythms or light-induced phase shifts in the 
behaviour and in immune responses, and they appeared to be linked with alterations 
in molecular clockwork 320, 329, 333. 
Clock time has been shown to modulate AHR activity. Furukawa and coworkers 
found that the induction of CYP-enzymes via AHR displayed circadian rhythmicity 
with the peak occurring in the middle of the night 334, thus making the inductive 
effect of an AHR agonist to be dependent on the exposure time, as confirmed later 
261. The interplay between clockwork regulation and the AHR is further supported 
by the findings obtained in Per1 knockdown mice: in these animlas the effect of 
TCDD on CYP induction was markedly enhanced in liver and in mammary gland 
335, 336. Furthermore, TCDD repressed the magnitude of Per1 and Per2 expression 
333, while disruption of these circadian clock genes abolished the diurnal fluctuation 
of the typical AHR mediated response, induction of CYP1A1 261. In 2013 Xu and 
coworkers showed that administration of another AHR-agonist, β-naphthoflavone, 
could block hepatic and SCN induction of Per1 expression in normal mice and in 
vitro 337. Hence, in the presence of an agonist there are several reports supporting the 
interplay between the circadian timekeeping and the AHR.  
2.4.3 Novelty avoidance and CTA after TCDD exposure 
TCDD induces specific alterations in feeding behaviour. Exposure of adult rats has 
been shown to cause not only a reduction in the amounts of feed consumed, but also 
alterations in feed preferences and strong aversive responses. Usually rodents prefer 
sweet and fatty tastes, but exposure of TCDD has caused a persistent avoidance of 
these types of foodstuffs as shown by Tuomisto and coworkers 12. In their 
experiments, the selective changes in chocolate consumption emerged rapidly, 
during the first dark period (chocolate was offered at the beginning of darkness) 
after the exposure. In that study, differently TCDD-sensitive rats were exposed to 
sublethal (but rather high, 10 – 100 µg/kg) doses of TCDD at different times of day 
during the light period. The diminished chocolate intake occurred independently of 
the time of exposure and of the sensitivity of an animal to overt TCDD-toxicity. 
Furthermore, the results of various experiments were concluded to favour the 
TCDD-induced neophobia: the novel food item aversion was most evident following 
simultaneous offer of the novel food item with TCDD exposure 12.   
The main characteristics of novel food item aversion were identified in the same 
study. A habituation period of 16 days to the selected novel food items before the 
exposure was a long enough period to familiarize the rats with these items and 
alleviated the immediate avoidance for chocolate or cheese. Nevertheless, selection 
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of chocolate as a food diminished and remained low for five weeks postexposure. 
These studies also indicated that the chocolate aversion endpoint - at the doses used 
- was not critically depending on the gender. It is noteworthy that in this experiment 
all of the novel food items (cheese, chocolate and sucrose) were freely available 
increasing the total energy intake and body weights of the rats on these special diets. 
Studies investigating the role of CTA in the feeding responses following TCDD 
are complicated by the persistent properties of TCDD and by its feeding and weight 
reducing effects. Nevertheless, in the studies of Pohjanvirta and coworkers, TCDD 
exposure induced a positive CTA response for saccharin at a dose 1000 µg/kg in 
H/W rats while the lower, 50 µg/kg dose proved ineffective in both H/W and L-E 
rats 279. Further support of CTA was the finding that differently sensitive rats 
avoided chocolate at the repeated testing after 19 days’ postexposure while in the 
same experiment there was no difference in novel food item (cheese) comsumption 
between the exposed and control rats at day 13 postexposure (i.e. cheese was offered 
as a novel food item on that day). This study revealed that the avoidance of 
chocolate on day 19 postexposure could not be related to the food energy because 
there was no neophobic response associated with cheese in the exposed rats. The 
emergence of the chocolate avoidance appeared to depend on its previous offering 
during the night immediately after the TCDD exposure 12.  
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3 Aims of the study  
Specific alterations in feeding and drinking behaviours following dioxin exposure 
have been observed in adult laboratory animals, but the sensitivity and the detailed 
characteristics of these effects among different laboratory animals have remained 
unknown. The aim of this work was to characterise acute feeding related responses 
in behaviour and in brain after a single TCDD dosing in adult rodents with different 
sensitivities to TCDD due to their recognized differences in their AH-receptor 
structures or expressions.   
 
The specific aims of this thesis were:  
 
1. To characterise the effects of TCDD on ingestive behaviours and determine 
their time- and/or dose-responses to provide a more dynamic and 
comprehensive perspective of the effects of TCDD (I-II, IV).  
2. To elucidate the possible role of the AHR in consummatory and aversive 
behaviours by comparing the feeding responses of studied animals (I-IV).  
Aims 1 and 2 will include following steps:  
Time- and dose-responses of novel food item avoidance will be assessed in 
adult rats, after a single low dose exposure of TCDD (I-II). 
The novel food item avoidance behaviour will be characterised and it will 
be determined if the avoidance is dependent on: animal strain and genotype, 
properties of foodstuff and the factors associated with the exposure of 
TCDD (I-II). 
Time-responses in feeding behaviour will be assessed, after two different 
TCDD doses. Studies will include characterisation of diurnal micro- and 
macrostructures of feeding and drinking behaviours in two differently 
TCDD-sensitive rat strains. These experiments will be done with and 
without TCDD (III-IV). 
3. To screen which areas of the brain are activated at 24 hours after a single 
TCDD exposure in two differently TCDD-sensitive rat strains (V). 
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4 Materials and Methods  
4.1 Animals and animal husbandry 
The rats and mice used in the experiments of this thesis are shown in tables 1 and 2. 
The sensitivities of these animals to TCDD lethality as well as their ED50 values 
(effective dose; causing a 50% response in exposed animals) to some toxic 
endpoints of TCDD are shown in Table 1. Table 2 displays a summary of 
experiments and their results. 
Table 1. Lethality of TCDD (LD50 values) along with ED50 values for EROD activity 
(measure of CYP1A1 induction) and body weight change for the animals 
used in the experiments (I – V). nd = not determined; ND = not 
detectable. 
Animal 
species; strain;  
sex 
Genotype Lethality, LD50  
(male/ female; 
µg/kg) 
EROD activity, ED50        
(male/female; 
µg/kg) 
Body weight change, 
ED50 
(male/female;µg/kg) 
rat; H/W Ahr
hw/hw, 
Bhw/hw 
> 10000 72 /  
> 9600 72 nd / 0.77 
85 nd / 19 85 
rat; L-E Ahr
 wt/wt, 
Bwt/wt 
18 73, 50 /  
7 – 10 73, 50 nd / 0.39 
85 nd / 6.3 85 
rat; line A Ahr
hw/hw, 
Bwt/wt 
> 10000 73/  
> 2000 73 nd / 0.15 
87 nd / 20 87 
rat; line B Ahr
 wt/wt, 
Bhw/hw 830 
73/  410 73 nd / 0.28 87 nd / 21 87 
rat; line C Ahr
 wt/wt, 
Bwt/wt 40 
73/ 19 73 nd / 0.14 87 nd / 5.5 87 
mouse; 
C57BL/6Kuo 
Ahr b/b, 
B?/? 
~350 
77/ >5000 77 
0.79338/1.01338*            
(or nd / 1.47 339)# nd 
mouse; AHR-
knockout 
C57BL/6  
Ahr-/-, 
B?/? ND ND ND 
* CYP1A1 mRNA induction, data from 338; # For ovariectomized C57BL/6 mice, data from 339 
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All rats (H/W, L-E, line A, B and C) were obtained from breeding colonies of the 
National Public Health Institute (Kuopio, Finland) maintained in a specific pathogen 
free barrier unit. In addition, mice (two genotypes of C57BL/6 mice, C57BL/6Kuo 
and AHR knockout mice, Ahr-/-) were bred at the same location, although the Ahr-/- 
mice originated from The Jackson Laboratories, Bar Harbor, ME, USA. Line A, B 
and C rats have been developed by cross-breeding H/W and L-E rats in this 
laboratory 73. FELASA recommendations were followed in regular health 
surveillances of animals and in the training of employees working with laboratory 
animals 340, 341. Health surveillances confirmed that the animals were free of typical 
rodent pathogens. 
In the experiments, healthy adult animals were used (Table 2). Before the start of 
the experiments, all animals were habituated for at least a week to ambient 
conditions and handling by the experimenter. In experiments I-II and V, the rats 
were individually housed in a stainless steel wire mesh cages (38 x 20.5 x 19.5 cm). 
Mice were kept individually in Macrolon® polycarbonate cages (36 x 19.5 x 15 cm) 
covered with wire mesh lids. Autoclaved aspen chips (Tapvei Co., Kaavi, Finland) 
were used as mouse bedding and nesting material. In experiments III – IV, 
Coulbourn Habitest® cages were used (see Chapter 4.3.2 and Figure 6). The air-
conditioned animal rooms were regulated for light (12/12 h light/dark cycle, lights 
on at 7 a.m.), temperature (22 ± 2 oC) and relative humidity (50 ± 20%). 
Temperature and humidity were monitored by a computer based system (Honeywell 
XBSI, Honeywell, Morristown, USA). 
In experiments I – II and V, the animals were fed with regular feed which was 
available together with tap water ad libitum, unless otherwise stated in the 
experimental design (Chapter 4.5 and Table 2). The regular feed for mice and L-E 
rats was Altromin 1314F feed (Altromin GmbH, Lage-Im Seelenkamp, Germany; 
energy content 12.5 kJ/g). H/W rats, line A, B and C rats and also L-E rats in the 
experiment (V) were fed with R36 feed (previously Ewos, Södertälje, Sweden and at 
the time of   experiments Labfor/Lactamin, Kimstad, Sweden; energy content 12.6 
kJ/g). In experiments III – IV, the rats were fed with 45-mg dust-free precision 
pellets (Bio-Serv®, Frenchtown, NJ, US). These pellets and tap water were available 
ad libitum. The energy content of the precision pellets was 15.1 kJ/g (or 3.6 kcal/g). 
During and after the experiments, all materials possibly contaminated with 
TCDD were collected and sent to a hazardous waste treatment plant (Ekokem Oy 
Ab, Riihimäki, Finland) for professional incineration. 
All the animal experiments were reviewed and approved by the Animal 
Experiment Committee of the University of Kuopio and Kuopio Provincial 
Government, and they were conducted in accordance with the Guidelines of the 
European Community Council directives 86/609/EEC.  
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4.2 Chemicals 
TCDD was purchased from the UFA-Oil Institute, Ufa, Russia. It was over 99% 
pure as confirmed by gas chromatography -mass spectrometry (GC-MC) 342, 343. A 
weighed amount of TCDD was dissolved in diethyl ether (BDH Laboratory 
Supplies, Poole, UK) for storage (in the dark, at room temperature). To prepare the 
dosing solution, an appropriate volume of TCDD-diethyl ether solution was mixed 
with corn oil (Sigma-Aldrich, C8267, St. Louis, MO, US) and the ether was allowed 
to evaporate thoroughly. Before each administration dosing solutions were mixed 
with magnetic stirrer and sonicated in warm water bath for 20 minutes. The 
administration volume for both TCDD and vehicle in all experiments was 4 ml/kg 
which was administered by intragastric gavage (i.g.) unless otherwise stated. From 
all dosing solutions at least one quality control sample was taken and stored in a 
freezer (-20 oC) for the confirmatory analysis of TCDD by gas chromatography-
mass spectrometry. Chemicals other than TCDD and all laboratory equipment used 
in the experiments are detailed in the original publications.  
4.3 Methods 
4.3.1 Indices of weight and food intake  
Two different variables were used for the body weight and food intake (I – IV). 
Since these rat lines grow at different rates and because the exposure affects both 
weight gain and energy intake, in addition to normal weight (g), the metabolic 
weights of rats were calculated. In this approach, the difference in the body weight 
and its possible effect on feeding were taken into account by relating the total daily 
feed consumption (g) to the metabolic mass of each rat [BW(kg) 0.67]. Hence, this 
estimate provides a measure of energy intake according the metabolic needs within 
the same species (discussed in 344, 345).  
4.3.2 Behavioural responses (I - IV) 
4.3.2.1 Characterisation of aversive responses (I-II) 
In experiments characterising details of novel food item avoidance and aversive 
behaviour after TCDD exposure, differently TCDD-sensitive rats and mice were 
exposed to TCDD. Various doses of the chemical were used to enable dose-response 
analysis and data modeling 85, 87. Regular chow in a novel form (in powdered form), 
chocolate (milk chocolate, Panda, Vaajakoski, Finland; energy content 23 kJ/g), 
0.25 % saccharin (S-6047, Lot. 075K00071 Sigma; contains no energy) and 10 % 
sucrose (ICN Biomedicals, 821713, Lot. 8681C, OH, USA; 10 % solution contains 
1.7 kJ/g energy) were used as a food stimulus. Saccharin and sucrose were dissolved 
in tap water. The experimental designs are described in Chapter 4.5 and in Table 2. 
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Unless otherwise stated in the experimental design, regular feed and tap water were 
available ad libitum.  
4.3.2.2 Drinking bouts and meals (III-IV) 
Before L-E or H/W male rats were moved into test cages (Fig. 6), they were 
habituated to eating 45-mg pellets for about one week. They were further 
accustomed to the Habitest® cages for at least one week, and the experiments were 
started only when their feeding and drinking had stabilized to a normal level 
(number of licks ca. 7000 and number of pellets ca. 450 per day). Only those rats 
meeting these criteria were included in the study. The data were gathered from pairs 
(one control and TCDD-treated rat at the same time).  
 
Figure 6. Automated device for monitoring of feed and water intake. 
Patterns of feeding and drinking behaviours were compared either across rat strains 
and subsections of time (III) or across treatments, measuring days and subsections of 
time (IV).  
A single meal or a drinking episode was defined as an event where any two 
consecutive pellets or licks had a lag shorter than five minutes between them. From 
the episodic data, various variables could be analysed reflecting feeding and 
drinking behaviors separately, both describing individual meals and drinking bouts 
but also the total consumptions within a day. In the analysis of circadian variation in 
behaviours, episodic data were pooled separately for each rat in chronological order. 
In all analyses, missing events (if a rat was not drinking or eating during a 
subsection of time) were encoded as zero values. 
Feed and water spillage in the experiments were controlled. In the total feed 
consumption, the spilled amount was taken into account, but not in feeding 
microstructural analysis because it was impossible to define afterwards the exact 
time and the specific meal during which the spillage had occurred.  
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4.3.3 Automated monitoring system (III-IV) 
The continuous feeding and drinking monitoring was performed with the Coulbourn 
Habitest® (Coulbourn Instruments, Whitehall, PA, US) system, controlled by 
Graphic State 3.02 software (Coulbourn Instruments, Whitehall, PA, US). This 
system is run by a standard computer and consists of a special cage equipped with a 
feeder and a lickometer described in original publications III – IV. Each time the 
feeder or the lickometer was activated, the time of the event was recorded in ms with 
reference to the start of the measurement. Stored binary data were further processed 
into feeding or drinking episodes with SPSS 15.0 (SPSS Inc., Chicago, IL, US). The 
measuring device is shown in figure 6. To prevent any data loss e.g. due to power 
failure, all measuring devices were connected to an uninterruptible power source.  
4.3.4 c-Fos Immunohistochemistry (V) 
C-Fos-immunostaining was used as an indicator of activated cells 346-348 in the brains 
of L-E and H/W rats. In the immunohistochemistry (V), the brains were cut into 30 
µm coronal, serial sections with vibratome (Leica VT1000S, Leica Instruments, 
Wetzlar, Germany). All sections were cryoprotected and frozen (-20 oC) until used 
for immunohistochemistry. Serial brain sections were stained free-floating using 
immunoperoxidase methods to visualize c-Fos protein. As a primary antibody, 
polyclonal rabbit primary c-Fos antiserum (1:2000, sc-52, Santa Cruz Inc. U.S., Lot. 
K089) was used. The exact protocol of immunostaining is described in original 
publication (V).  
C-Fos positive cells were mapped using an integrated hardware-software 
application: the set-up contains a PC-computer connected to an ECLIPSE E600 
microscope (Nikon, Tokyo, Japan) via CCD colour video camera (HV-C20, Hitachi, 
Tokyo, Japan). Data were collected with the aid of the software programs Stereo-
Investigator and NeuroExplorer (MicroBrightField, Colchester, VT). To determine 
the total number of activated, c-Fos positive cells, all darkly, intensively stained 
neuron nuclei of relevant size and shape were counted in the target area (µm2, 
achieved during the plotting).  
4.3.5 Statistical analyses and assessment of ED50 
In the statistical analyses, different versions of SPSS software (SPSS Inc., Chicago, 
IL, US) were used, and p-values of less than, or equal to 0.05 were considered 
significant. In the behavioural analyses (I-IV), the data consisted of repeated 
measures from the same animal that had been measured for time periods of varying 
lengths. However, the repeatability and the dependency of an observation from a 
previous one and for each animal was taken into account in the statistical analysis of 
the data 349. For continuous responses, a linear mixed model and for count responses 
a generalized linear Poisson model with generalized estimating equations (GEE) 
were used. Autoregressive and exchangeable correlation structures were used 
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accordingly.  Type III tests of fixed effects with Sidak’s adjustment for multiple 
comparisons were used.  
In experiment V, immunohistochemical data were assessed by two-way analysis 
of variance after verifying the homogeneity of variances by Levene’s test. A full-
factorial model with contrast coefficient was calculated to assign the statistical 
differences among the groups. If the interaction of strain and TCDD-treatment was 
not statistically significant, the data were analysed by the analysis of variance 
followed by post-hoc testing (Dunnett’s 2-sided t-test and Dunnett’s T3-test).  
ED50 values and their confidence limits for TCDD induced chocolate avoidance 
(III) were estimated by benchmark dose analysis [Benchmark Dose Software 2.1.2. 
(BMDS), by US EPA (http://www.epa.gov/ncea/bmds/index.html)]. The continuous 
Hill model was used for the estimation. The form of the response function in Hill 
model is:  
 
Y[dose] = γ + [ν *dosen/(kn + dosen), 
 
where Y[dose] is the observed effect at [dose];  γ = Intercept (control effect, 
Ymin); k = Slope, (ED50); n = Power factor, Hill coefficient; ν = Sign, (Ymax – Ymin). 
 
In the model, variance was assumed to change as a power function of mean 
value. The non-homogenous variance for the ith dose group was estimated as 
follows:    
 
δi
2 = α[µ(dosei)]ρ, 
 
where α = Power parameter, µ(dosei) = observed mean (from the model) for the 
ith dose group and ρ = Coefficient of variation. 
  
In the Hill model, ρ was set to 1 because in the present data, variances were 
proportional to the mean. Furthermore, in the model, α was restricted to be ≥ 1 and n 
> 1. If α < 1, then the slope of the dose-response curve becomes infinite at the 
control dose.  
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5 Results  
5.1 Characteristics of TCDD-induced novel food item 
avoidance after low dose exposure 
The avoidance of novel food items appeared to be an extremely sensitive, rapid and 
persistent response to TCDD at doses far below those affecting energy intake or 
body weight gain (I, II). Intake of a palatable food item, chocolate, was rapidly 
diminished in response to TCDD. The difference in the cumulative intake achieved 
statistical significance at 5.5 hours after the exposure (Fig. 7). In this preference test, 
control male rats of line A shifted their feeding to chocolate while the TCDD treated 
counterparts (3 µg/kg, i.g.) preferred normal feed.   
 
Figure 7. Male line A rats (n = 8 per group) avoided novel chocolate (A) offered in 
conjunction with the exposure of TCDD (3 µg/kg) at the beginning of the 
darkness (time 0) while controls preferred chocolate to chow (B). Lines 
represent means (± SE) of cumulative intakes within groups. The time 
points when the differences between groups reached statistical 
significance are shown in panels (Linear mixed model for repeated 
measures, ***p ≤ 0.001, **0.001 < p ≤ 0.01, *0.01 < p ≤ 0.05).   
The avoidance of novel food item was not restricted solely to chocolate: rats avoided 
palatable liquids (H/W rats, II: Fig. 6) and a feed that had a novel texture (line C 
rats, II: Fig. 3). The total avoidance was most persistent (for several weeks in H/W 
rats, II: Fig. 2) when there was a lag of one day or less with the exposure and the 
offering of chocolate. TCDD treated H/W male rats ate less chocolate than controls 
up to 76 days (end of observation) in case the chocolate presentation coincided with 
the exposure of TCDD. If the lag between exposure and chocolate offer was one 
week or more, or if the rats had been habituated to a novel food item, aversive 
behaviour either disappeared in male H/W or line C rats (II: Figs. 2 and 6) or was 
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relieved in L-E females (II: Fig. 7). However, the relief of avoidance of chocolate 
was transient, it lasted only for a day. It is noteworthy that the one month 
habituation to a liquid saccharin solution in H/W males (II: Fig. 6) and for chocolate 
in L-E females (II: Fig. 7) differed between the groups the former being ad libitum 
while the latter was provided in restricted amounts daily. While saccharin contained 
no energy and did not affect weight gain, by restricting the amount of energy-rich 
chocolate (0.2 – 0.5 g per day) it was possible to avoid enhanced body weight gain 
during the habituation period. 
The administration route of TCDD appeared to interfere with the aversive outcome 
(II: Fig. 5). In line A male rats, the dose of 3 µg/kg by gavage appeared to have the 
same effect as 100 µg/kg administered intraperitoneally: the 24 hours’ chocolate 
consumption following exposure was significantly less than that of their corn-oil treated 
counterparts. At that time, intraperitoneal administration of 3 µg/kg of TCDD did not 
have any effect on chocolate consumption. Thus, the total energy intake (per metabolic 
masses of rats, kJ/kg0.67) was enhanced due to increased chocolate consumption equally 
to controls. Nevertheless, within 48 hours of exposure, chocolate consumption was 
diminished also in the group treated with 3 µg/kg dose intraperitoneally.     
5.1.1 Role of the conditioned taste aversion? 
Small, 3µg/kg (i.p.) dose of TCDD to dioxin-resistant line A rats induced 
conditioned taste aversion to the novel food they had received at the exposure. One 
week after the exposure, the rats were challenged with one novel food item and also 
with the food item they had been offered at the exposure. If the exposed rats were 
offered powdered feed, they chose chocolate; if they were offered chocolate, they 
chose powdered feed in the selection test (II: Fig. 4).      
5.2 Animal species and strain (AHR genotype) determining 
differences in the feeding and drinking responses; role of 
the AHR in the regulation of feeding and aversive 
behaviour   
5.2.1 Novel food item avoidance 
Within and between species differences in the TCDD-induced novelty avoidance 
were determined using C57BL/6Kuo male mice and in differently dioxin-sensitive 
rat lines. To assess the dose-response and ED50 value of TCDD-induced novel food 
item aversion, the mean data of three days’ chocolate consumption for the rat lines 
A, B, and C was used. During the first days at doses below 1 µg/kg (i.g.), all rats 
displayed some variations in their chocolate consumption. Therefore the mean value 
of three days’ consumption was used in the ED50 estimation. However, chocolate 
consumption diminished significantly already on the day of exposure in line A and 
C rats at doses equal or higher than 3.0 µg/kg and 1.0 µg/kg, respectively. In line B 
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rats, the reduction reached significance during the second day after the exposure at 
doses equal, or higher than 3.0 µg/kg. In all (male) rats, exposure caused a total 
aversion at dose 3.0 µg/kg (Figure 8). The ED50 values (µg/kg) appeared to be 0.36 
for line A, 1.07 for line B, and 0.34 for line C. For the confidence intervals, see 
Figure 8 and I: Table 1. Neither body weights nor normal feed consumptions (I: Fig. 
1) were altered in the experiment.  
The appearance of TCDD-induced novelty avoidance for chocolate in species 
other than rats was established by using wildtype C57BL/6Kuo mice. TCDD-
induced avoidance for chocolate appeared at both tested doses, 5 and 100 µg/kg 
(i.g.), although the neophobia-like avoidance was weaker and more transient than 
that encountered in rats, lasting only for two days (I: Fig. 2). In control mice, 
chocolate was palatable despite its novelty: although the difference in chocolate 
consumption during the exposure day did not quite reach statistical significance 
between individual TCDD-treated groups and controls (5 µg/kg vs. ctrl: p = 0.159 
and 100 µg/kg vs.ctrl: p = 0.078, linear mixed model), the diminishing effect of 
TCDD did achieve statistical significance (p = 0.027, linear mixed model).  
 
 
Figure 8. TCDD exposure induced dose-responsive chocolate aversion in 
differently dioxin-sensitive male rats of lines A, B and C. Average 
chocolate consumption (mean ± SE) for three consecutive days following 
TCDD is shown for each group (n = 7, range 3 – 10), but in the statistical 
evaluation, the repetitive nature of observations was taken into account. 
Significant differences (p ≤ 0.05, linear mixed model) from the control 
level within each strain are shown as capitalised letters A, B, C, 
respectively. Differences among lines at identical TCDD doses are 
indicated as follows: *between lines A and C and # between lines B and 
C. ED50 values with 95% confidence intervals were estimated by 
benchmark dose analysis.   
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5.2.2 Diurnal micro- and macrostructures of feeding and drinking 
behaviours in differently TCDD-sensitive rat strains – with and 
without TCDD 
In the automated monitoring of diurnal feeding and drinking activities, TCDD-
sensitive L-E and TCDD-resistant H/W rats displayed distinct differences. It is 
noteworthy that although the figures and tables of original publication (III) show the 
data combined for the whole observation period (seven days), the repeatabality of 
measures was accounted in each rat and measuring day in the analysis of data. 
Statistical significances of results can be found in the original publications (III, IV) 
with supplementary data included (IV; Suppl. Figs. 1 – 3 & Suppl. Tables 1 – 2). 
The main difference between rat strains without TCDD-treatment was found in 
H/W rats which exhibited no peak in their feeding activity during the morning light 
shift (III: Figs. 1 and 2) whereas in L-E rats, the highest activities were recorded 
during the dawn and dusk (III: Figs. 1 – 4). Daytime was the time of least feeding 
activity in L-E rats whereas H/W rats diminished their feeding and drinking before 
the dawn and started to increase consumption already during daytime. Thereafter 
H/W rats increased feeding and drinking steadily towards the night, the time of 
highest activity in these rats (III: Figs. 1 – 4). Meal sizes varied according to the 
general circadian feeding activity patterns. Furthermore, at the times of lights-on and 
lights-off L-E rats had more meals that were larger than those of H/W rats (III: Fig. 
I). L-E rats had longer lasting meals and ate at a lower rate compared with H/W rats. 
Although H/W rats had more drinking episodes than L-E rats, the bouts were larger 
and lasted longer in L-E throughout the day when compared with H/W rats (III: Fig. 
3).  
TCDD exposure affected intakes at different times of day in these rats: in the 
sensitive L-E strain, feeding and drinking were suppressed mainly at the dawn, 
around the light transition phase (at supralethal dose 100 µg/kg, IV: Fig. 3A,C & 
6C,E) whereas in H/W rats both doses, 100 or 1000 µg/kg reduced food intake (in 
grams, IV: Fig. 3B) during all phases other than the morning. This tended to shift 
diurnal feeding of H/W rats from daytime to night (after 100 µg/kg) or to evening 
(after 1000 µg/kg) while the proportion of morning feeding relative to total diurnal 
food intake remained mainly intact (IV: Fig 3D). Drinking was most severely 
suppressed in H/W rats during night at both doses (IV: Fig. 6D). Except for the 10 
µg/kg for L-E rats, all TCDD doses induced increased feed spillage (IV: Figs. 
2C,D).  
Following a sublethal dose of 10 µg/kg to L-E rats suppression of daily food 
intake achieved statistical significance from the fifth day onwards (IV: Fig. 2). This 
diminished intake of food was a result of slightly fewer meals during daytime (IV: 
Fig. 4C). In addition, the total feed intake (g) was suppressed slightly below the 
controls during morning, the time of active food consumption in this strain (IV, Fig. 
3A). Total daily drinking tended to remain below the level of the controls 
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throughout the observation period (IV: Fig. 6A), mainly due to the fact that there 
were fewer drinking bouts in the morning (IV: Fig. 7A).  
In L-E rats, the high 100 µg/kg dose suppressed meal size (except during 
daytime, IV: Fig. 4C). The phase with the most severe suppression occurred in the 
morning when the reduction in meal size (from the 1st day after the exposure) was 
accompanied later by fewer meals (from the 4th day postexposure, IV: Figs. 4A,C). 
In this group, the proportion of daytime drinking enhanced as a result of increased 
numbers of daytime drinking episodes. Furthermore, the size of a drinking bout 
showed a downward tendency at all other phases except during the daytime (IV: 
Figs. 7A,E).  
In the resistant H/W rats, both TCDD doses caused rather similar alterations in 
feeding and drinking patterns despite the 10-fold difference in the dose (both 
sublethal). In the H/W rats, the response in total food intake was bidirectional (IV: 
Figs. 2A,B): meal frequency diminished almost throughout the day supplemented 
with a slight but significant decrease in meal size during the first few days 
postexposure  (IV: Figs. 4B,D). After about one week, meal sizes and their durations 
started to increase throughout the day although the frequency remained below that 
exhibited by the controls (IV: Figs. 4B,D,F). The drinking was most severely 
affected during the night, when the decreased size of drinking bouts significantly 
diminished total amount of drinking (IV: Figs. 6D, 7F).  
5.2.3 Role of the AHR in the novelty avoidance behaviour 
Rats with different AHR structures but fully functional AHR had only minor 
differences in their sensitivity to TCDD-induced novelty avoidance (I) and the 
characteristics of the effect did not seem to depend on the sensitivity of an animal to 
overt dioxin toxicity (II). In order to seek further support of the possible role of the 
AHR mediating the TCDD-induced chocolate avoidance, it was studied in Ahr-/- 
mice. In these animals, no signs of exposure related aversion were detectable (I: Fig. 
2). Corn oil treated control Ahr-/- mice were neophobic and avoided novel chocolate 
on the day of exposure, whereas their TCDD-treated counterparts (100 µg/kg) ate 
chocolate avidly, in similar amounts to the wildtype control mice. Thus, mouse 
genotype and TCDD treatment had a significant interactive effect on chocolate 
consumption [F(1, 20) = 5.269, p < 0.05, linear mixed model].  
5.3 Involvement of the CNS in the early phase of TCDD 
intoxication 
During the lights-on hours of the day, the effects of 50 µg/kg (i.p.) exposure to 
TCDD on the induction of immediate early gene activation were minor in the brains 
of H/W and L-E rats. Twenty-four hours after the exposure, TCDD induced an 
increase in the total number of c-Fos positive cells in the dorsal nucleus of 
premammillary area (V: Table 1). Treatment with the positive control, leptin, 
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increased the total number of c-Fos positive cells and the density of these cells in 
ventromedial hypothalamic nucleus (VMH) and arcuate nucleus (Arc). Combined 
treatment with TCDD and leptin increased the total number of c-Fos positive cells in 
VMH as compared with combined corn oil and saline treatment (V: Table 1).   
As was the case in H/W rats, TCDD exposure on its own in L-E rats did not have 
any significant effect on c-Fos-ir in the studied areas of the brain as compared with 
the control treatment. Treatment with leptin - with or without TCDD exposure - 
increased the total number of c-Fos positive cells in VMH (p = 0.003) and in Arc (p 
= 0.013). In PaVN (p = 0.088) and in ventral premammillary nucleus (p = 0.07), 
leptin treatment exhibited a subtle tendency to decrease the activation. Combined 
treatment with leptin and TCDD in L-E rats did not cause a similar upward trend in 
c-Fos-ir to that found in H/W rats.  
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6 Discussion  
6.1 Studies of energy homeostasis and body weight regulation 
– why use TCDD and animal models?  
Research on food intake and metabolism is an extensive field of science, but there 
are only a few compounds capable of inducing persistent anorexia and which could 
thereby be utilised in the research into diminished feeding and starvation 
mechanisms. Therefore the exposure of dioxins, especially the 2,3,7,8-tetrachloro-
dibenzo-p-dioxin - a potent anorexigen, represents a good model to induce a wide 
variety of effects on metabolism and on comsumption of various foodstuffs. 
Although a vast amount of data regarding the effects of TCDD does exist, there 
were no details of time- and dose-responsive definitions of the feeding related 
outcomes in behaviour. Hence, the focus of this work was characterising in vivo 
effects of TCDD on neural activation as well as on diurnal feeding, drinking, and 
avoidance behaviours at mainly sublethal TCDD dose levels. 
Different animal models have been used to screen the possible factors affecting 
the variation in responses of TCDD, as the animal model, exposure time and the 
dose are critical determinants of the outcomes. Animal models with different 
sensitivities to dioxin toxicity can be exploited to find the explanations for the 
wasting phenomenom: outcomes occurring equally at rather similar, low dose level 
in differently dioxin-sensitive animals are of interest or vice versa, those that differ 
between substrains. Evidently, high (lethal) and low dose effects involve very 
different phenomena within the studied organisms. The low dose effects are 
especially interesting with respect to the feeding regulatory pathways involved in the 
lowered food intake and maintenance of the weight at a lowered level after TCDD 
administration 276. In many instances, it is impossible to differentiate the high dose 
effects from secondary phenomena to diminished feeding and body weight loss, and 
therefore it is important to undertake time- and dose-response studies with TCDD. 
One property of interest in TCDD-toxicity is the cytosolic aryl hydrocarbon 
receptor, AHR. In addition to mediating the effects of xenobiotics, it participates in 
the regulation of many biological events, as described in a recent book edited by 
Prof. Pohjanvirta  93. Hence, by using TCDD, a well-known and potent agonist of 
the AHR, it is possible to broaden also the understanding of the AHR’s role in many 
physiological and biological processes.  
Feeding and its neural regulation have been the targets of scientific studies for 
decades. Ethologists published consummatory studies already at the beginning of the 
20th century 350 and the first publications of neophobia appeared in the 1960’s 351. As 
early as the 1940’s, the importance of hypothalamic nuclei in the feeding regulation 
was acknowledged 352, 353. Furthermore, the concept of an idea of neural correlate of 
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the defended body weight settling point was proposed by the British scientist 
Gordon Kennedy at that time 147, 148, supported later by Hervey 354. In the 1960’s, 
Hoebel published his studies regarding self-stimulation of hypothalamic nuclei in 
the control of feeding and the role of gastric load in this effect 355. These preliminary 
works used rather robust techniques in rats, and at that time, little was known about 
the neural connections involved. Tracing studies and targeted neural stimulation 
have thereafter provided more information of the whole hypothalamic network, and 
following exploitation of various molecular and visualisation methods, and 
identification of neuropeptides – namely leptin 356 – the field has taken huge steps 
forward. 
Behaviour constitutes an essential part of feeding and drinking, and is a good 
example of an experiment in which in vivo models are essential. On the other hand, 
food intake is one of the most common variables measured in experimental studies. 
Nevertheless, even in a strictly controlled experiment results can be biased by many 
factors,  exemplified by study settings, sampling frequency, animal model, feeding 
protocol or gender or species 17, 357-360. Simply choosing the controls is sometimes a 
difficult task: the common use of ad libitum fed controls can be criticised due to 
their unnatural excess food consumption and the lack of natural physical activity. 
These “controls” have appeared to be susceptible to suffer metabolic disorders and 
age-related deficits in neural functions, leading to shortened life-span in comparison 
with their restrictively fed counterparts 361, 362. On the other hand, although a 
sedentary lifestyle with excess calories may be considered as rather atypical among 
wild animals, it does resemble current lifestyle among humans rather well.  
All experimental in vivo studies are limited by the fact that necropsies can be 
performed only once, and the necropsy in conjunction with its timing represents a 
significant determinant for the results of the experiment. In many instances, ex vivo 
or in vitro studies provide time- and cost-efficient ways to study biological events 
and their mechanisms. Nevertheless, metabolic and cellular processes that are 
related in a spatio-temporal manner to the experimental treatment, as is the case with 
TCDD, result from chain(s) of event(s) that are difficult to model thoroughly in in 
vitro. For many years in several fields of science mechanistic studies will need to 
rely on animal testing, despite all the progress in in vitro methodologies and the 
techniques emerging from computerised data modelling. The maximal utilisation of 
experimental data includes all of these parameters, thereby favouring also the 
reduction and refinement of the animal experiments. It is a fact that without animal 
experiments, a vast amount of the current knowledge in medical science and in drug 
therapies would never have been discovered, as has been concluded by many 
scientists 161, 363, 364.     
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6.2 Characteristics of novel food item avoidance as clues of 
TCDD-targeted regulatory pathways - neophobia or CTA? 
Several memory processes are involved in feeding (e.g. review 201). Taste learning is 
a necessary and adaptive response appearing during the evolution to ensure the 
proper identification of nutritive foods and to promote the dietary variability, which 
can enhance the fitness of the individual. Bearing in mind that rodents are unable to 
vomit, when confronted with a new food item they may use two different strategies 
to avoid intoxication as discussed in Chapter 2.3.2. It is known that while neophobia 
dissipates and appetitive memory is formed if no malaise occurs after the tasting of a 
new food 154, CTA is routinely acquired after a single trial with CS and US, and may 
persist for extended periods, although a short time lag (from minutes to hours) is 
needed for CTA to develop 203. US intensity (e.g. dose of LiCl, a typical malaise 
inducing compound) affects CTA, i.e. a low intensity US may not lead to altered 
gene expression and protein synthesis, and thus is not able to evoke permanent 
modifications in neural circuits.  
Previously it had been shown that TCDD-exposure evoked an intense novel food 
aversion in the rats of the same strain or line 12 that were used in this thesis. Previous 
results were in favour of TCDD-induced neophobia although the interpretation of 
the studies was complicated by the fact that in most cases there were several 
palatable food items available simultaneously, and the rat was expected to make a 
choice between them. Furthermore, when Tuomisto and coworkers studied the role 
of habituation on TCDD-induced food aversion, the availability of palatable food 
items (ad. lib.) increased the total energy intake, and thus the weight gain in rats 12. 
Since the doses were also rather high, one could speculate that the rats had attained 
the lowered body weight level as a response to TCDD by diminishing their 
consumption of high energy foodstuffs. Here it was confirmed that chocolate 
avoidance was not related to the body weight change: neither the habituation nor the 
TCDD exposure affected weight gain. In further support of specific avoidance 
behaviour is the fact that in these experiments, exposed rats had not lost their normal 
appetite since their consumption of standard feed remained unaffected. The reason 
for the strong avoidance of chocolate remains unknown, but may be related to its 
properties: it is a mixture of many nutrients and tastes, and has high energy content. 
Although fat appeared to be unfavourable after TCDD 284, 286, in the previous study 
the cheese aversion was not as intense as that encountered with chocolate 12. 
Furthermore, aversive behaviour can be affected by the stimulus itself 191, 365. It is 
also possible that cacao-derived compounds of chocolate (such as flavonoids)366 are 
able to activate AHR and potentiate the aversive effect of TCDD.  
 The discrimination between the effects, whether TCDD caused novelty 
avoidance or CTA, is clearly dependent on the study settings. Many findings here 
are in favour of novelty avoidance, i.e neophobia induced by TCDD while some 
parts of the data support a role for CTA. Intense novelty avoidance was closely 
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linked to exposure, occurring at extremely low dose levels, and emerging very 
rapidly in adult rats - within hours (I, II). Avoidance was not restricted to chocolate: 
very low doses of TCDD caused aversion of liquid food items or of familiar feed 
presented in a novel form. When chocolate was offered for the first time one week 
postexposure, neophobic response was similar to controls. Two weeks postexposure 
there were no signs of neophobic response in both TCDD-treated and control 
animals, raising the possibility that rats had accustomed to the cholate smell in the 
animal room by that time.  Preceeding habituation even for a month (with an item 
not affecting daily energy intake) did not prevent chocolate aversion. The effect of 
habituation might be stimulus dependent as the preceeding habituation with liquid 
saccharin (ad. lib.) was able to alleviate avoidance. This difference in observations 
might also derive from different genders, as it has been shown that prenatal exposure 
to TCDD induced saccharin avoidance in female pups but not in males 367. The 
gender differences in responses to feeding challenges are found also in the H/W and 
L-E rats 279, 284. One possibility to explain the difference in the outcomes may arise 
from different habituation. The energy-deficient saccharin was offered freely 
throughout the day to the male H/W rats whereas the chocolate was only a tiny piece 
offered during daytime to the female L-E rats. Thus, further studies are still needed 
to clarify the possible gender differences and the effect of preceeding habituation 
protocol in TCDD induced aversion. 
CTA was supported by the finding that only that food item offered at the 
exposure was avoided one week postexposure (II). However, studies to reveal the 
role of CTA in the feeding responses following TCDD are complicated by the 
persistence of TCDD in the body. In general, offering of the CS without US should 
ultimately lead to extinction 212, but the kinetics and long elimination half-life of 
TCDD challenge the testing of CTA-response without US. With repeated offers of 
CS, the US should not be present any longer. In experiments with TCDD this means 
that in a (full-grown) rat the body-burden of TCDD-exposure is still almost the same 
one week later as it was on the day of exposure (the elimination following first-order 
kinetics and the elimination half-life of a single sublethal dose of TCDD being about 
16 - 31 days 32, 368, 369). In that sense the time of one week used here to test the CTA 
response was definitely too short. In the previous studies conducted by Pohjanvirta 
and coworkers only a  high dose of TCDD (1000 µg/kg) was effective in evoking a 
CTA response in H/W males 279. However, since a low dose of TCDD (3 µg/kg) to 
resistant rats caused a long-lasting chocolate aversion, with attenuation of this 
response starting only after 6 wks (II), this is interpreted that a low dose of TCDD is 
able to form and consolidate persistent, long-term aversive memory in rats. 
Although after a week, there was a positive CTA response, the question of whether 
the TCDD-induced avoidance is merely defective alleviation of neophobia or related 
to conditioned taste aversion cannot be unambiguosly answered. These results 
would need confirmation with testing of the CTA response after a sufficiently long 
enough time following a low dose exposure to TCDD. In practice, this would 
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require at least 4 – 5 elinimation half-lives (when there is 1/16 or 1/32 of the dose 
remaining in rats) representing about 64 – 155 days, depending on the 
interindividual and interstrain variation 40, 369. Although that is a substantial part of a 
full-grown rat’s lifespan, these kinds of behavioural experiments can be performed. 
Houpt and coworkers have detected the CTA response and c-Fos activation in the 
NTS for as long as 6 months, after only a few pairings with US and CS which had 
been conducted 6 months previously 230. 
Although one cannot make any precise definition of avoidance behaviour, it was 
an extremely sensitive response and there were hardly any sensitivity differences in 
the dose-responses between the strains (representing the type I dioxin response 85) 
(I). TCDD efficacy values for the novelty aversion were not calculated, neither the 
relative changes in efficacy ratios. Therefore, the classification of the aversion as an 
endpoint of TCDD toxicity in the rats with different AHR genoypes is based on the 
similarities in the ED50 values for the aversion and for the EROD-activity (Figure 8 
and 87, and I, Table 1). The calculations of exact estimates for efficacy 85, 87 would 
provide more detailed information of the aversion.  
Whether the avoidance can be extended to other behaviours in addition to 
feeding remains to be clarified, but surprisingly, even their regular feed when 
dispensed in a novel form was recognised as novel and avoided by the exposed rats. 
This excludes the possibility of novel tastes or flavours being the sole inducers of 
avoidance behaviour. It should be mentioned that it has been shown previously that 
TCDD-treated rats do not suffer deficits in their tasting abilities 275. 
Based on this data, it seems that after about two elimination half-lives (after 6 
weeks) the learning process of new association with chocolate started in H/W rats 
(II), but it remains to be tested whether the malaise-inducing taste, chocolate, had 
become palatable again when the TCDD had been elimated, requiring about 110 
days in H/W rats 369. Possibly an even longer time period would be needed, as the 
effects of (rather high, 1000 µg/kg) TCDD dosing on gastric preloads were tested 
and positive responses observed even after 100 days 370. Studies of this 
phenomenom and its regulatory pathways could shed some light on this behavioural 
phenomenon, and in that respect it might be possible to identify which taste memory 
process is responsible for the effect. Interesting target areas would be NTS and PBN, 
since the taste stimuli communicates first of all with NTS and PBN 200, 201. 
Furthermore, to ensure the consolidation of long-term memory, i.e. persistent CTA, 
permanent modifications need to occur in the regulatory sites – e.g. IC, CeA and 
basolateral amygdala 201, 212. This applies also to the strengthening of appetitive 
memory trace during the CTA extinction, with responses occurring in IC, perirhinal 
cortex and amygdala 232. Hence, with regard to the possibility that activation of 
AHR by TCDD causes CTA that becomes extinguished when the dose is eliminated 
means that the new association with the taste should be learned, along with the 
corresponding changes in protein synthesis should occur in the target areas of the 
brain 191, 371, 372. A commonly used method to study the involvement of selected 
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brain areas is protein synthesis inhibition (e.g. 232). Furthermore, use of the novel 
imaging methods of the brain (such as functional magnetic resonance imaging or 
positron emission tomography) could provide enlightening insights into the 
processes involved in the actions of TCDD. These could reveal the temporal 
responses in very same animals - provided that the repeated anaesthesia and other 
treatments would not harm the studied outcome.  
6.3 Circadian ingestive patterns in TCDD-sensitive and –
resistant rats providing indications of physiological status 
with and without TCDD  
Food consumption in TCDD induced wasting is a critical variable, and the extensive 
difference in dioxin-sensitivity among the two rat strains makes this animal model a 
good tool with which to study the effects of TCDD exposure. However, the 
circadian consummatory patterns of these strains were unknown even without 
TCDD exposure, and therefore an automated monitoring system was devised to 
allow monitoring of food and water intakes throughout the day.  
The results of this thesis showed that circadian activities of feeding and drinking 
were very different between the rat strains (III). Especially during the daytime, the 
hunger state differed between the H/W and L-E rats. Although in both strains most 
feeding (~2/3 or more of total eaten amount) and drinking (~3/4 of total number of 
licks) occurred during darkness (lights were off from 7 p.m. till 7 a.m.), L-E rats 
exhibited two feeding peaks around the time of light changes. The daytime, fully 
illuminated phase was the time of lowest feeding activity, with fewest and smallest 
meals of shortest duration in L-E. In contrast, H/W rats had their lowest intake 
around the morning light shift. They started to feed before noon and consumed 
increasing amounts of feed towards the night, with a similar mode of activity being 
detectable in drinking.  
This observation raises many issues which need to be considered. First of all 
hunger and satiety signalling in these animals would be predicted to be in opposite 
phases in the morning or daytime, during normal working hours and thus, at the 
most typical time for collecting tissue samples. Furthermore, these differences in 
circadian activity may reflect differences in the circadian fluctuation of regulatory 
genes and proteins. Although it is not known in these two rat strains, there is  a 
report that in two other rat strains the different behavioural rhythms did reflect 
fluctuations in many physiologic parameters (such as temperature or blood glucose) 
as well as hippocampal serotonin secretion 357. It is known that in mice, Ahr 
transcripts express tissue-specific fluctuation patterns during the day 329. Thus, 
depending on the time of observation, there can be between two to three-fold 
differences in AHR protein 328 or mRNA expression 329. H/W and L-E rats are 
known to display about two-to three-fold differences in Ahr expression with and 
without TCDD 84, 373, however: the impact of circadian fluctuation was not evaluated 
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in these experiments. Collectively, these findings highlight the importance of 
circadian clockwork to be taken into account when this rat model is utilised in the 
experiments. In these rats further studies to clarify the amount of circadian 
fluctuation in the gene and protein expression would be essential.  
As H/W rats with a mutated AHR grow at a faster rate, being heavier than L-E 
rats at adulthood, it would be interesting to study whether there is some overlapping 
regulatory pathway between metabolism, the circadian clockwork circuitry, and the 
AHR which could account for the difference in phenotype. In order to pinpoint the 
differences in feeding that may reflect the difference in the body weight between 
H/W and L-E, the variables with largest differences in behaviour should be 
evaluated. It is noteworthy that the total daily food consumption (grams) on two 
selected days (III, Table 1) did not differ between the strains, especially if 
consumption was related to body weight. The differences appeared when one 
considered the circadian timing of feeding and drinking behaviours, and the rates of 
consumption. Throughout the day, the feeding rate was higher in H/W rats than in L-
E, but meals lasted longer in L-E rats. The drinking bouts of L-E rats were also 
longer almost throughout the day compared with those of H/W rats. Meal and 
drinking bout sizes varied during the day but in general, the fluctuation patterns 
followed the circadian feeding activity patterns in both strains. In general, H/W rats 
ate more and had more numerous meals during daytime and night in comparison 
with L-E rats. It has been shown that caloric intake does not necessarily determine 
the differences in weight or adiposity 264-266, 374, but meal patterns during a day and. 
microstructures of meals are important determinants for the weight gain 265, 374. 
Furthermore, there exist data indicating that correct circadian rhythmicity is 
essential for the control of weight and metabolic health 264, 266, 375. Thus, descriptive 
behavioural data of circadian feeding and drinking patterns can reflect the general 
activity rhythm and may provide some indications of body weight control in living 
organisms. In that sense the higher daytime activity of H/W rats may make them 
more vulnerable to gain weight in comparison with L-E rats. 
In the presence of a potent AHR-agonist, TCDD, feeding and drinking patterns 
were differently altered in rats (IV). Both strains were treated with two different 
doses as a single exposure in the middle of the day: in the L-E rats the 10 µg/kg dose 
was sublethal (but high) and 100 µg/kg lethal 50. In H/W rats both doses were clearly 
non-lethal 72. In all groups, feed intake and body weight followed a downhill course 
following exposure. These responses have been classified as type II dioxin responses 
107. Sublethal TCDD dose induced a similar reduction in feeding in both H/W 
groups, this being larger (about 50% reduction) and occurring more quickly (within 
two days) than that induced by 10 µg/kg in L-E rats  (about 30% reduction after five 
days postexposure). In general, the declines in feeding and drinking occurred mainly 
at the times of the highest consummatory activities: in L-E rats during the morning 
hours and in H/W in the middle of the day or night. TCDD induced phase-shifts in 
circadian rhythmicity of feeding and drinking, the exception being the dose 10 µg/kg 
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(for L-E rats). In L-E rats (following 100µg/kg dose) severe hypophagia flattened 
the diurnal peaks in the feeding, but as the daytime food intake was not affected 
(daytime food intake remained at its low level throughout the 5-day study period), 
the relative proportion of daytime feeding increased above the controls during the 
last two days. A similar phase-shift to enhanced daytime activity was detectable in 
drinking; in fact, the number of daytime drinking episodes displayed an increasing 
tendency. In contrast, the previously observed shift towards increased daytime 
feeding in H/W rats 274, 275 was now not observable during the first two weeks after 
TCDD. However, the phase-shift noted by Pohjanvirta and Tuomisto appeared at 
two weeks postexposure, following a 1000 µg/kg dose or higher. The present data 
indicates that during the first two weeks, the consummatory activities shift towards 
evening (1000 µg/kg) or night (100 µg/kg) in H/W rat. Feed and water intake 
remained close to zero during the mornings and in the daytime, but by the end of 
study, during the last four days rats dosed with 1000 µg/kg slightly appeared to 
increase their daytime feed consumption. Thus, the observation period for two 
weeks appeared to be too short to detect alterations in feeding and drinking patterns 
in resistant rats during the whole recovery phase and thereafter. It remained unclear 
whether circadian patterns in H/W rats were still about to change, and if this were to 
occur, how and when it happens. 
The changes in the eating rate as a response to TCDD appeared to depend on 
meal size (IV, supplementary data). If the smallest meals (below 0.54 g) were 
excluded, in all of the TCDD-dosed groups the eating rate became slower as 
compared with their controls, the effect being least pronounced in 10 µg/kg dosed L-
E group. On the other hand, if all meals were included, eating rates appeared to 
display an uphill curve. The consumption of very small meals has a clear elevating 
effect on the eating rate (III), thus the increased rate of all meals including the 
smallest ones reflects the increased numbers of very small meals after the TCDD. 
On the other hand, this bidirectional response is a good example of how the 
definition of the term “meal” affects the result(s). It is common that this kind of data 
is sensitive to the methodology used in the analysis, and in the definitions of meal or 
drinking episode. Therefore comparisons between studies can be difficult and 
special attention needs to be paid to the methodological issues 376, 377.  
It is of interest that the treatment with sublethal dose of TCDD appeared in some 
way to balance the feeding rhythm of H/W rats: from the first day postexposure, a 
decline to almost zero feed intake occurred during daytime, and as a result the 
relative proportion of total food consumption during evening and night was 
enhanced. In addition, TCDD diminished the meal frequency of H/W rats, most 
consistently during the daytime throughout the study. At the sublethal 10 µg/kg dose 
in L-E rats, the total feed intake (g) was suppressed slightly below the controls 
during morning, the time of active food consumption in this strain. However, the 
effect did not change their diurnal distribution of feed intake. Furthermore, a slight 
but on some days a statistically significant reduction in meal number occurred 
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during the daytime in these rats. These feeding effects might be considered as type I 
responses to dioxin, because both phenomena occurred at the sublethal doses in both 
rat strains. However, additional experiments are needed to verify this hypothesis and 
to study the dose-responses of these feeding effects, at equally low doses in both 
strains. In this experiment the initiation of weight loss occurred in both strains, but it 
remained unknown whether the timing of diminished intake at the usual activity 
phase and/or the diminished motivation to start eating (diminished meal frequency, 
especially during daytime) is the critical factor(s) for weight loss. However, recently 
the meal frequency is suggested to be an important determinant for the weight gain 
in humans 378.  
In the sensitive L-E rats, a lethal dose seemed to permanently override any 
factors related to within-meal satiation, to the physiological control of meal size, 
while the factors related to meal initiation i.e. satiety remained almost unchanged (in 
mornings also the satiety was increased). In other words, physiological control of 
feeding and body weight maintenance had been overwhelmed by enhanced satiation 
of meals after the lethal dose, and no correction in feeding occurred after the 
exposure. There was no attempt to increase food intake and thus prevent death.  On 
the other hand, lethal and close to lethal doses are known to induce drastic effects in 
various tissues 3, 53, at the same time as there is a collapse in nutritional balance by 
disturbances in fat and glucose metabolism 46, 86, 91, and these changes also 
contribute to wasting and death. In the progress towards severe wasting, food intake 
appears to play a minor role. This hypothesis is supported by the facts that provision 
of additional energy or other dietary manipulations (such as force-feeding) were not 
able to prevent lethality, although these actions were able to modify the dioxin-
induced weight loss and time to death 283, 284.  
It would be important to clarify the changes in circadian patterns also in 
spontaneous activity and/or in indirect or direct measures of intermediary 
metabolism or thermogenesis in these rats. For example, activity data would have 
provided more information of the increased spilling of feed among TCDD-treated 
rats, a behaviour that was first reported some time ago 273 although its etiology is 
unknown. It certainly represents a motivated behaviour to start a meal as a rat takes 
a pellet from feeder but for some reason the pellet is not consumed, instead it is 
dropped. The reason might relate to increased satiety (as was observed following 
TCDD exposure) or it is possible that dioxin exposure causes a stereotypic stress 
response detectable as feed spillage, or the TCDD-treated rats may simply have 
increased need for gnawing 379. Although spillage was detected in both strains, blood 
chemistry results of H/W and L-E rats (with the dose of 50 or 100 µg/kg) did not 
show a similar stress response between strains: in L-E rats serum corticosterone 
levels were increased or at least displayed an upward tendency in comparison with 
controls whereas in H/W rats this did not happen 295, 380. Thus, one hypothesis to 
explain the increased spillage is that TCDD induces a hoarding behaviour: instead of 
accumulating extra energy as fat, the animal is trying to store extra food by hoarding 
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381. Hoarding could be viewed as an attempt to maintain body weight set-point at a 
target level despite fluctuations in energy sources 382. The hypothesis of increased 
hoarding supports the original proposal that TCDD induced wasting was a 
secondary response to TCDD with the main target being the lowered body weight 
set-point 276. Further studies of food spillage and its regulation could provide 
important information of TCDD toxicity. 
6.4 Role of the AHR in the regulation of aversive behaviour or 
in the control of feeding? 
Novelty avoidance is induced in rats at extremely low doses of TCDD, 
independently of their sensitivity to dioxin toxicity. The lack of any avoidance 
behaviour in Ahr-/- mice strongly supports the need for a functional AHR in this 
response. The dose-response of novelty avoidance following TCDD exposure in 
differently dioxin-sensitive rats is well correlated to the dose-response of CYP-
enzyme induction in liver 87. It can be postulated that avoidance behaviour 
represents a way to restrict consumption of potentially harmful foods whose 
consumption is stringently correlated to metabolic activation. It is not known how 
the activated AHR mediates its effects to prevent novel food consumption, but it 
seems that consumption is prevented for a considerable time (II), reflecting possibly 
the long elimination half-life of TCDD.  
In phylogenetic terms, AHR is an ancient protein with a considerable degree of 
structural and functional homology between different vertebrate and even 
invertebrate classes, although the primitive AHR forms in some invertebrates are 
incapable of binding dioxin 383, 384. In many freshwater or marine invertebrate 
species, there seems to be a lack of AHR homologues, or the issue is unknown. 
However, in these animals, induction of CYP-enzymes does occur in response to 
environmental PAH exposure 385, 386. Interestingly, freshwater invertebrates are 
known to display extremely sensitive behaviour to avoid PAH-polluted sediments in 
their habitats and they strive to minimise their own exposure to these pollutants 387. 
Thus, by some unknown mechanism they are able to sense PAH-compounds and 
actively avoid them by adjusting their behaviour accordingly; a strikingly similar 
phenomenom appears in these invertebrates as found in rodents. Whether avoidance 
is a more general and equally sensitive response across other species throughout the 
animal kingdom will require further experiments.  
The role of AHR in mediating neophobia or in the regulation of conditioned taste 
aversion and taste learning will only be clarified by conducting further mechanistic 
experiments. Future mechanistic studies are important, as there are human 
individuals who are highly predisposed to food neophobia and in addition, 
neophobia is a common observation in some sicknesses. For neophobic individuals 
or those suffering from illness-induced neophobia or cancer cachexia, it is 
challenging to devise new diets or even to provide a normal and nutritionally 
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balanced energy intake. The impact of hedonic and reward value of food and 
psychological distress is likely to have an important role in loss of appetite e.g. in 
cancer patients, and therefore no single treatment is available to increase their 
appetites 388. Some strategies have been applied to combat food neophobia (e.g. 389, 
390). Food neophobia seems to have inherited, genetic components in human 
populations although the genes involved are not known 391-393.  Interestingly, in 
studies of neophobia, the list of avoided foodstuffs contains many compounds that 
are able to activate AHR: not only fruits and vegetables (containing indolo(3,2-
b)carbazole  and flavonoids 394, 395), but also herring was disliked by Finnish young 
adults who were neophobic 392. Baltic herring is known to contain dioxin-like 
chemicals and therefore its consumption is restricted in Finland by EU regulations 
(latest update on year 2011: EU act 1259/2011). Thus, it could be hypothetised that 
metabolic induction and activation of AHR (at least in vertebrates) could be one of 
the factors linking the signals from the food and the environment to the behavioural 
responses. At present nothing is known about the AHR’s role in human neophobia. 
Nevertheless, the behavioural findings of TCDD-induced novelty avoidance in 
rodents clearly point towards a role for AHR in the host defence to prevent the 
consumption of potentially harmful foodstuffs.  
AHR is widely expressed in the organs acting as barriers of the body. In addition 
to liver or BBB 396, 397, it has been found in the skin, lungs, placenta and in the 
intestine (e.g. 396, 398-400). In-deed, there are several findings pointing to a 
physiological role for the AHR in host defence. The ligand-activated AHR induces 
inflammatory responses 401-403 but on the other hand, recently it has been shown that 
a functional AHR is needed for the maintenance of the immune system in the 
intestine 135, 137 where AHR has a role in mediating anti-inflammatory signals 
(reviewed in 404). Furthermore, the findings of this thesis support the proposal of 
gastrointestinal target(s) for TCDD action. At sublethal doses, the administration 
route affected the aversion outcome (II): after intraperitoneal and intragastric 
administration, the latter route proved to be more effective at diminishing intake of 
the novel food item. Although avoidance behaviour and wasting syndrome appear at 
a very different doses, and represent two different phenomena (type I and type II 
responses, respectively), it is possible that there is some common peripheral 
pathway or mechanism involved in the regulation. The early work Stahl and 
Rozman 405 suggested that in order to observe diminished feeding a peripheral 
administration route was needed. Further support to the proposal that there are 
responsive sites to TCDD within GI-tract comes from the early finding from our 
laboratory. TCDD appeared to increase the sensitivity of exposed rats to nutrient 
information arising from the GI-tract 370. TCDD sensitises rats to postingestive 
satiety signals and H/W rats showed aberrant responses to metabolic challenges, for 
example they were unable to increase feeding after 2-deoxy-glucose treatment 274, 
275. It has also been shown that after TCDD exposure fat is the least preferred 
macronutrient 12, 286. Interestingly, AHR appears to work in concert with fatty acid 
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translocase Cluster of Differentiation 36 (CD36) 143, 406, one of the proteins involved 
in ‘fat taste’. Fatty-acid specific receptors are expressed within taste receptor cells in 
both the oral cavity and GI-tract where they participate in the regulation of fat intake 
159. It is not known whether the AHR has any role in the tasting system, but if an 
AHR-agonist can modify CD36 expression also in taste receptor cells, it may be 
directly able to modulate feeding responses within the GI-tract. Furthermore, 
stomach is known to be a target tissue of AHR activation in animals with a 
constitutively active AHR 407. In Ahr-/- mice focal proliferative lesions were 
observed, suggesting that AHR regulation may be involved in cell homeostasis in 
gastric epithelium 121. Moreover, also human patients have suffered from GI-
symptoms in cases of severe TCDD intoxication 408, 409. During recent years new 
discoveries have been made regarding the interplay of gut-brain axis. There is 
evidence that in the gut, enteroendocrine cells (secreting peptides) and 
enterochromaffin cells (secreting serotonin) use the same signalling pathways as the 
taste and olfaction, and they are therefore able to respond to luminal contents within 
stomach and intestine directly by affecting taste receptors and transmitter or peptide 
release (for a review, see 410). It would be interesting to determine how the GI-tract 
and the tasting and odour pathways are involved in effects of TCDD. Existing data 
are scant, but our own short-term study showed that bilateral transection of the 
chorda tympani nerve prevented the decrease in feeding after TCDD (8.5 µg/kg, L-E 
rats) on the third day, supporting a contribution of the tasting system to the feeding 
responses elicited by TCDD (unpublished findings). The chorda tympani nerve is a 
branch of the facial nerve, mediating both the taste and trigeminal sensation of the 
tongue 411, thus it would be highly interesting to study whether its transection has 
any effect on novelty avoidance.  
It is not known whether the difference between H/W and L-E in growth rate 
results from the difference in the AHR structure, but it seems that an interplay 
between AHR signaling and food intake regulation, circadian rhythmicity and 
energy metabolism do contribute to normal body weight level. Recent data from 
these rats have revealed further differences between the strains in terms of the genes 
involved in many metabolic pathways 86, and serum levels of leptin and insulin 
which were in H/W rats about two-fold higher than the corresponding values in L-E 
rats 295. The circadian fluctuation in these parametres 412 was not evaluated in these 
experiments and it may provide some amount of variation (and confounding) to the 
responses. Nevertheless, it is known that AHR is involved in many physiological 
processes related to growth 121, 124, 126, and the early growth of Ahr-/- mice is retarded 
75, 119. It is possible that the difference in the AHR structure combined with its ability 
to interfere with circadian clockwork and energy metabolism contributes to the 
differences in phenotype and in the feeding behaviours of L-E and H/W rats. 
Nevertheless, in the presence of TCDD, phase-shifts in feeding and drinking were 
observed. As the AHR, circadian clockwork and intermediary and xenobiotic 
metabolism are linked together (e.g. 142, 329, 337), the findings of the circadian activity 
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(III, IV) emphasize the interplay between the AHR and the circadian clockwork in 
feeding regulation, with and without TCDD.  
These studies mainly utilised male animals, but there are known to be gender 
differences in responses to feeding challenges after dioxin [(II) and e.g. 279, 284]. 
Furthermore, in the animals used in these experiments there is a contrasting gender-
related sensitivity difference to TCDD lethality: male rats are more resistant than 
females while in mice the situation is inverted (Table 1). Many biological events or 
toxic outcomes have not been studied in female animals (or the estrous cycle has not 
been taken into account in the data analysis). Often male animals are used in order to 
avoid estrous cycle dependent rhythmic oscillations in several hormones, 
metabolism, and even in feeding 329, 412, 413. Although it is known that TCDD affects 
expression of many hormones including estrogen (e.g.414) and this may as such 
evoke effects on feeding behaviour 413 it would be important to clarify the TCDD-
induced feeding behavioural responses also in females.  
6.5 Involvement of CNS in dioxin-induced  acute responses -  
some possible signalling pathways  
The mechanistic pathway(s) through which activated AHR modulates feeding and 
drinking remained obscure since the focus of this thesis was not to examine 
regulatory mechanisms. Thus, in this respect this thesis raises more questions than it 
answers, but the results presented here may help to make more targeted questions 
than previously possible. Now it seems clear that TCDD exposure has distinct 
effects on both feeding regulation and on taste memory processes. These studies 
showed that TCDD influenced (at least) two distinct pathways of feeding regulation: 
the first is involved in regulating aversive behaviour (representing the type I dioxin 
response 85) and the second mediating TCDD-induced wasting (type II dioxin 
response). Whether the regulatory pathways of these effects overlap at any phase of 
dioxin intoxication will be a very interesting question to be solved in future 
experiments.  
The CNS has multiple functions in energy homeostasis controlling meals, long-
term energy balance, and locomotor and oromotor activities (Figure 5). 
Additionally, it handles external information originating from the ambient 
environment and has control over emotions, cognition, learning and memory - 
processes involved also in feeding behaviour. Many important sites within brain are 
involved in the regulation (as overviewed in Chapter 2.3 and shown in Figure 5), but 
hypothalamus is considered to occupy a key position to control feeding and energy 
balance 16, 188. Therefore the analysis of c-Fos focused especially on hypothalamic 
areas where it was anticipated to find the early effects of TCDD exposure in L-E and 
H/W rats. In a previous study c-Fos protein levels were shown to be upregulated but 
only after 3 – 4 days of TCDD exposure 346. However, in the study (V) the effects of 
TCDD (50 µg/kg) alone were minor during the daytime, in both sensitive and 
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resistant rat strains. This was slightly surprising since in another study with similar 
treatments for the rats of the same strain, there were profound alterations in 
hypothalamic mRNA expression of regulatory peptides 415. C-Fos staining proved to 
be a valid method because leptin, a positive control in this study, appeared to induce 
c-Fos activity in two target areas, VMH and Arc, in both rats similarly as has been 
reported 416, 417.  It is likely that specific neuropeptide stainings might have resulted 
in more similar outcomes, and might have produced supporting data to the mRNA 
work. Nevertheless, the results of the activated brain areas reflect the findings of the 
feeding behaviour studies: during daytime H/W rats were more active than L-E rats, 
and more pronounced effects both to the TCDD and to the leptin treatment were 
found in the brains of H/W rats when they were compared with L-E rats.  
During the early phase of intoxication TCDD induced more pronounced effects 
on drinking than on feeding (IV). Unfortunately, the main drinking regulatory areas 
(pituitary gland, NTS, circumventricular organs, or anterior cingulate cortex and IC) 
418, 419 were not analysed in the c-Fos study. Moreover, hindbrain areas or subregions 
of cortical structures might be interesting target areas in dioxin intoxication because 
these extra-hypothalamic areas are known to have a regulatory role in conditioned 
taste aversion and novel food item avoidance 200, 201 - behaviours which appeared 
soon after TCDD exposure. C-Fos activity could be used to screen the areas in the 
brain at different stages of CTA 201, e.g. in PBN Fos-mediated gene transcription 
seems to be necessary for the CTA memory formation 420. However, screening of 
these areas and their involvement in dioxin effects would need a more precise timing 
of the sampling, and different experimental set-ups to clarify the aversive responses 
and those mediating the feeding and drinking behaviours. 
In order to search the regulatory pathway targeted by the TCDD, feeding effects 
of TCDD can be compared to those of anorectic agents or treatments to tackle 
obesity. Many of them have been shown to diminish meal size, i.e. they increase 
intrameal satiation by facilitating processes leading to meal termination. For 
example, gastric surgery has been claimed to cause rather similar effects as the lethal 
dose of TCDD in L-E rats: diminished meal size and slowing down of meal rate, 
leading to a permanent weight loss. Furthermore, gastric surgery caused an 
avoidance of fat as an energy source whereas increased energy expenditure played 
no role in weight loss, these effects being similar in both rats 421 and humans 422, 423. 
In these effects, GLP-1 seemed to be involved (reviewed in 424). One can also 
compare TCDD effects with the effects of anorectic compounds. For example, 
fenfluramine is an indirect serotonergic agonist and it seemed to diminish meal size 
and eating rate at low doses, although at 2- 4 times higher doses it also reduced meal 
frequency. At lower, but still anorectic doses of fenfluramine did not affect drinking 
at all while at higher doses it reduced selectively feeding-related, prandial drinking 
376. Although meal related regulation or circadian expression patterns of serotonergic 
transmission in the brains of L-E or H/W are unknown, Unkila et al. 72 showed that 
brain serotonergic activity was affected by TCDD in sensitive L-E but not in 
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resistant H/W rats. The turn-over of serotonin in several areas of the brain was 
elevated, and plasma free tryptophan negatively correlated with the body weight 
changes following exposure 425. Furthermore, immediately postexposure (within 1 – 
4 hours) activities of hypothalamic dopaminergic and serotonergic systems  have 
been shown to be lowered  in L-E rats (H/W rats were not studied) 426, although 
subsequently it has been confirmed that the dopaminergic system can be induced by 
TCDD, in different study set-ups 427, 428. Since site-specific perturbations in 
serotonergic and/or dopaminergic systems have potential to modulate feeding 
behaviour 429, 430, it is possible that these neurotransmitters are involved in the 
behavioural responses induced by TCDD. As dopamine release is strongly and 
positively related to desire (the food reward value) and increase in the motivational 
aspects of feeding 15, 188, reduced dopaminergic activity may make the food less 
appetising after TCDD exposure. Serotonergic and dopaminergic systems are also 
important mediators in the taste memory encoding 201. Moreover, in addition to the 
fact that increased serotonergic activity is known to be anorectic, it is also known to 
increase drinking 431, evidence that the increased seronergic activity may have a role 
in the behavioural responses in L-E rats during early phases of the intoxication 
following a lethal TCDD dose.  
There is a study with hypothalamic blocks that provided some indications of the 
regulatory pathways laying behind the feeding and drinking behavioural effects of 
TCDD, during daytime 415. Hypothalamic blocks were collected from the brains of 
L-E and H/W rats after similar treatments as in (V). The findings revealed that 24 
hours after TCDD in L-E rats the mRNA level of the ghrelin receptor was clearly 
increased whereas that of the neuropeptide Y 5-receptor (receptor for neuropeptide-
Y) was decreased in comparison to controls. In H/W rats, a corresponding increase 
in hunger signal ghrelin did not exist whereas neuropeptide Y 5-receptor mRNA 
expression was decreased 415. These findings are supported by the ghrelin assays 
conducted in serum samples. In serum, ghrelin levels were increased in L-E rats 
immediately and remained high (i.e. on days 1, 4 and 10 after 100 µg/kg dose of 
TCDD), whereas in H/W rats a significant increase in ghrelin was evidenced only at 
the last measurement (10 days post exposure) 295, reflecting the increase in feeding 
at the start of recovery phase (IV). Thus, the timing of behavioural responses may 
reflect the timing of ghrelin signalling: in both rats the ghrelin increase indicates an 
emerging hunger state, but due to enhanced satiation in L-E rats and increased 
satiety in H/W rats, food intakes remain at low level (IV). Since ghrelin is a short-
lived hunger signal, it is believed to regulate the latency to eat and thereby meal 
frequency having no effect on meal size 161. In order to initiate feeding, ghrelin not 
only activates the NPY system, but also the agouti-related petide and orexin neurons. 
NPY activation leads to an increase in food intake (NPY increases meal size by 
acting in the lateral hypothalamus and meal frequency by acting in the PaVN 432), 
prolonged meal duration, and delayed satiety whereas the effects of orexins are 
linked to increased arousal, although they also modulate hindbrain satiety signalling 
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432, 433. Thus, studies of the downstream and upstream pathways in ghrelin-signaling 
after TCDD would be of special interest. Research in this field is scant, in addition 
to the mRNA study by Linden et. al. 415, increased expression of NPY mRNA has 
been reported in Sprague-Dawlay rat hypothalami at a sublethal dose (15 µg/kg) 434. 
Nevertheless, this response was detected only at six days post exposure and 
therefore it may reflect a secondary response to TCDD. 
Another possible peptide involved in the feeding effects of TCDD is glucagon. 
The glucagon response differed between L-E and H/W rats 295: glucagon levels were 
higher in TCDD-treated L-E rats than in controls or feed-restricted counterparts. In 
H/W rats, glucagon levels were lowered below controls only on the fourth day 295. 
Glucagon is known to acutely reduce food intake and body weight gain, and increase 
energy expenditure and improve glucose homeostasis. Importantly, it is believed to 
have endogenous role to the control of within-meal satiety (i.e. satiation) at 
physiological doses, while anorectic effects occur at much higher dose levels, 
elicited by a range of stressors 435, 436. Thus, at first glucagon in L-E rats may 
participate in the increased satiation to reduce meal size, then contributing also to 
the wasting. Furthermore, as it has been shown that combined administration of 
glucagon and GLP-1 induce ‘superanorexia’ at the doses by which neither of them 
alone is capable of reducing feeding 435, possible role(s) of glucagon and/or GLP-1 
in TCDD-induced wasting provide interesting study targets.  
Apparently, many feeding regulatory pathways are involved in dioxin effects.  
For example, the rapid increase in serum FFA level 295 is likely to induce the 
anorectic tone 159 in the brains of L-E rats. Interestingly, gastric peptides have been 
shown to participate not only in the regulation of meals but also in the regulation of 
long-term energy balance and in mediation of food reward and hedonic value. 
Ghrelin is known to have a role in signalling of reward value of meal, central amylin 
may act as an anorectic signal independent of metabolic state of an animal, and 
GLP-1 has a dual role both in meal regulation and in the regulation of energy 
balance, since it has target sites in both the brain and the periphery. In particular, the 
feeding regulatory role of ghrelin has been a target of intensive research during 
recent years. Ghrelin appeared to interfere with dopamine release in NAcc where 
dopamine release is related to the reward value of meal, and it has been postulated 
that an intact dopaminergic signalling is necessary in order to achieve ghrelin’s 
effect on mediating the food-reward value (reviewed in 410, 424). Ghrelin is thought to 
be involved in saccharin preference, too (410, 424). In rats, it has a role in olfaction by 
increasing olfactory sensitivity and stimulating exploratory sniffing to identify and 
select foods, being therefore an important regulatory component transducing cues 
from the environment and nutritional status to the brain 437. Furthermore, ghrelin 
enhances food-seeking behaviours such as hoarding 381. Collectively, all these 
findings indicate that ghrelin-signalling pathways may be involved in mediating not 
only the TCDD-induced high dose effects on feeding, but it might also have a role in 
other behavioural effects that are initiated at sublethal doses of TCDD.  
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Vagal pathways have an important role in the control of food intake and 
transducing bidirectional metabolic and food- and nutrient-derived signals between 
the brain and periphery 16, 170, 188. In the view of the fact that TCDD exposure 
modulates many gastrointestinal responses (Chapter 6.4), it was an interesting and 
surprising finding that hepatic vagotomy did not prevent wasting and affected feed 
intake only marginally in H/W rats (and not at all in L-E rats) 438. However, this 
finding point towards a possible role of the BBB in the TCDD-induced feeding 
responses. In order to gain access to the CNS from the bloodstream, compounds 
need to cross the BBB. They can either use non-saturable transport (such as PYY 
and GLP-1) or saturable transporters at the BBB (insulin, leptin, ghrelin, amylin, PP) 
439. Peripheral regulators may also alter the normal functions of the endothelial cells 
in the BBB, and in that way modify the transport systems (e.g. the permeability) of 
the BBB. Additionally, they can alter the secretion of cytokines, nitric oxide or 
prostaglandins from the endothelial cells 440, 441, which subsequently have their own 
effects on energy balance and feeding 442, 443. The BBB seems to play a role in 
illness and aging induced anorexia (reviewed in 444). As the function of BBB is 
sensitive to oxidative stress and inflammatory responses 445, in the acute phase of 
immune reaction, activation of cytokines can inhibit feeding by acting either at 
endothelial and perivascular cells of BBB or by directly affecting neurons and 
receptors to induce anorectic effects 444. Since dioxin exposure modulates expression 
of gastrointestinal hormones 295 and causes an increase in the release of 
inflammatory cytokines 446, these compounds might induce direct effects on BBB 
per se. In rodent models, activation of AHR has been shown to up-regulate (in vivo 
and in vitro) expression and transport activity of cellular ATP-driven efflux 
transporter proteins, such as P-glycoprotein in the BBB 447. Unfortunately, saturable 
or non-saturable transport systems were not studied. At present nothing is known 
about the role of BBB in TCDD-induced diminished feeding, or on the effects of 
TCDD exposure on ghrelin, leptin or insulin transport into the brain.  
6.6 Future challenges for the mechanistic studies and risk 
assessment of dioxins   
There is lack of data on how the molecular clockwork fluctuates and how its ticking 
can regulate metabolism in either H/W or L-E rats. The crosstalk among AHR, 
circadian players and key metabolic proteins has been established (reviewed in 448), 
as exemplified by the close interplay between the expression of AHR, BMAL1 and 
peroxisome proliferator-activated receptor-α 142.  Thus, although AHR is a known 
mediator of toxic responses, it might be that its roles in adaptive, housekeeping and 
developmental processes are evolutionarily of critical importance 325, 449. In that 
sense it can be hypothetised that the aversion to food xenobiotics represents one of 
the housekeeping roles of AHR. Moreover, its constitutive role in feeding behaviour 
might be related to environmental adaptation, a proposal that is further supported by 
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our recent data regarding AHR protein and mRNA levels in starvation: in 
comparison with controls or TCDD-treated counterparts, feed restricted animals had 
a high hepatic AHR protein level and a low mRNA level after ten days of 
progressively diminished food availability 295. The situation was reversed in lethally 
TCDD-treated L-E rats at the same time point 295. Furthermore, at sublethal doses, 
AHR activation modifies feeding in many ways (I, II, IV). During evolution, it may 
have been beneficial that an organism is capable of assessing the properties of food 
at many levels: its taste, energy content and nutritional value. The interplay between 
AHR and circadian clockwork may ensure that the behavioural activity, along with 
metabolism of nutrients and xenobiotics, occur in an appropriately controlled 
manner throughout the day. In recent years, the crosstalk between the clockwork 
system and the cell’s metabolic state together with behavioural rhythms has been 
shown to be an important contributor for health and longevity (for reviews, see 233, 
450). There is evidence of increased appetite after sleep loss, e.g. shift-work has been 
associated with a variety of diseases and metabolic disorders. In addition, the 
converse is true: in many obese or diabetic animal models the diurnal rhythmicity of 
molecular clockwork and/or behaviour is impaired (reviewed in 233, 234, 254, 451). An 
interesting finding supporting the tight interplay and importance of diurnal 
rhythmicity on body weight control and metabolism was published in 2012 by two 
groups: despite similar caloric intake with ad libitum fed controls, timed availability 
prevented a variety of adverse effects of consumption of a high-fat diet. Thus, the 
coordinated control between the circadian clockwork and components of 
intermediary metabolism seemed to function appropriately only if the switch to the 
higher energy intake was restricted to the nighttime, the normal active period of 
these rodents 264, 266. These findings highlight the importance of identifying the 
players involved in coupling the circadian clockwork to other biological processes. 
On the other hand, the contribution of circadian clockwork and fluctuation of genes, 
proteins, and behaviour are important issues to be considered in biological 
experiments, although it is all too often neglected. 
In addition to environmental contaminants such as dioxins, there are many other 
AHR ligands or their precursors that are able to induce AHR mediated signaling 
pathways (as reviewed e.g. 9, 110), or activation may occur even without ligand 
binding (reviewed in 10). Many AHR ligands are present in food, and humans are 
commonly exposed to them when they ingest such foods, e.g. cruciferous 
vegetables. These AHR ligands do not induce AHR mediated toxicity apparently 
due to their rapid metabolism as they are substrates for the induced xenobiotic 
metabolising enzymes. In contrast, it seems that AHR is necessary for the 
maintenance of many normal physiological events, such as cell cycle control 452 and 
in the gut, AHR activation is needed for the expansion of intestinal lymphoid cells. 
Furthermore, activation of AHR by dietary compounds has been claimed to inhibit 
release of proinflammatory cytokines and to attenuate the symptoms of colitis – in 
mice and humans 404. The use of AHR ligands as therapeutic agents to treat 
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inflammatory or autoimmune diseases is nowadays attracting increasing research 
interest 453. However, the role of AHR in inflammation seems to be a double-edged 
sword as the TCDD-induced inflammatory pathway in adipose tissue 454 has been 
linked with metabolic disorders and obesity. In obesity, inflammation of adipose 
tissue contributes to the resulting metabolic disorders, thus by affecting adipose 
tissue (via inflammatory and many other pathways) endocrine disrupting 
environmental pollutants, such as TCDD, have been suggested to act as obesogens 
455. Thus, in the future, the understanding of the positive and negative, dose-
dependent, and chronic vs. acute effects of AHR activation by different ligands in 
different tissues will be a great challenge for studies of AHR biology as well as for 
dioxin risk assessment.  
In addition to disturbances in the energy balance, TCDD induces different types 
of alterations in feeding behaviour that are both immediate and persistent with low-
dose levels, as it was shown here. Whether the mechanisms of the two effects, 
perturbed body weight set-point and novelty avoidance, intersect warrants further 
dose-response studies. In particular, extremely low dose experiments are needed to 
study the mechanistic pathways involved in the aversive responses. Solving the 
mechanism mediating these effects would provide clues to the mechanisms involved 
in disturbed food intake in humans, such as in acute illness anorexia, appetite loss in 
aging, or cancer-related cachexia. Novel therapies for treating unnatural food intake 
in disease states would result in better nutrition, and it would improve health and 
prolong lifespan. Hence, further studies to determine the role of AHR in the 
regulation of neophobic responses, food intake and energy balance could represent 
promising therapeutic targets, as well as advancing our understanding of AHR 
biology and dioxin toxicity.   
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7 Conclusions with future 
perspectives 
Findings of this thesis characterise effects of TCDD-exposure on ingestive 
behaviours, namely on feeding and novel food aversion. The results highlight the 
role of the AHR in the regulation of food aversion and feeding behaviour. It 
appeared, that dioxin-exposure induces two kinds of effects on food intake: novel 
food aversion and diminished food intake, but only the latter of these leads in a 
dose-dependent manner to wasting and death. Single dosing is needed to induce both 
effects but their dose-responses are very different. The sensitivity of a rat strain to 
aversion of novel food items is independent from that of acute toxicity of TCDD 
(type I dioxin response), whereas the severity of diminished feeding is clearly 
dependent on the animal species and strain (type II dioxin response). Minor 
differences in the activated hypothalamic areas were detected in the brains of L-E 
and H/W rats during the daytime, at 24 hours post exposure. 
 
More precisely: 
* Important novel finding was that dioxin-exposure induces a rapid and sensitive 
behavioural response in adult animals. Novel food aversion emerges within hours. 
Importantly, it occurs after a very low dose of TCDD that does not affect the energy 
intake of an animal. ED50 values for chocolate aversion in differently dioxin 
sensitive adult rats were 0.34 - 1.07 µg/kg.  
* The emergence of food aversion is linked to the simultaneous presentation of the 
novel food item with the TCDD exposure while it does not depend on the actual 
properties of foodstuff.  
* Novelty aversion was detected also in mice. Although it was more severe in rats 
than in mice, in AHR-deficient mice aversion was not present.  
* Aversion to novel food items was affected by the administration route of TCDD: 
the effect emerged earlier after intragastric dosing than after intraperitoneal 
injection. This implies that there are responsive sites modulating food intake within 
GI-tract, and/or in close contact with the GI-tract.  
* Rat strains with different AHR receptor structures display distinct differences in 
their feeding behaviour, even without TCDD exposure. The most pronounced 
differences were detected in the feeding activity patterns: while in the sensitive L-E 
strain the times of lights-on and lights-off were the active feeding and drinking 
periods, in the resistant H/W strain consummatory activies were rather evenly 
distributed throughout the day. Differences in circadian feeding patterns in 
combination with a faster eating rate may contribute to enhanced weight gain and 
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growth in H/W. Also TCDD-exposure caused phase-shifts in activity patterns of 
feeding and drinking, indicating the the interplay of circadian clockwork, AHR, and 
feeding regulation. 
* High, lethal dose of TCDD seems to override control of satiation (diminished size 
of a meal or a drinking bout) in rats, while sublethal doses adjust feeding regulation 
and processes that affect satiety (meal frequencies decreased).  
* A week after the exposure, resistant rats started to recover: they increased both 
meal size and duration (above the controls). Diminished meal frequency kept the 
total food intake below the controls throughout the observation period (two weeks). 
Thus, factors related to satiety regulation in H/W rats seem to be the most important 
determinants in maintaining the body weight level of exposed rats below that of 
controls. 
FUTURE PERSPECTIVES: 
* The findings of distinctive meal and drinking patterns, with and without dioxin 
exposure, suggest that the differential AHR structure of L-E and H/W rats does 
contribute to the regulation of circadian feeding and drinking patterns. Although 
there is evidence for the interplay of circadian clockwork, AHR, and metabolism 
(reviewed in 448), the possible direct or indirect impacts of AHR status and activation 
on feeding regulatory genes and proteins, and importantly, on their circadian 
fluctuation, deserve further scrutiny.  
* The ligand-activated AHR seems to act to prevent further ingestion of harmful 
compounds, thus this acute effect (at low doses of TCDD) can be considered to 
promote enhanced survival of the organism. It is not known whether the activation 
of AHR by ligands other than TCDD would exert similar aversive effects as TCDD. 
Furthermore, it would be interesting to study if this finding is restricted to feeding or 
can it be extended to other novelties, and whether the AHR-mediated behavioural 
response can be observed in different animal species and in both genders. 
* The AHR-activated pathways regulating the aversive behaviour remain to be 
elucidated, but this finding provides additional support for the proposal that 
activated AHR has an acute house keeping role extending to behaviour.  
* Further experiments will be needed to determine if there is any common 
component in the pathways regulating aversion and feeding responses to TCDD. 
* Further experiments to elucidate the role of AHR in the regulation of aversive 
feeding behaviour might be of importance for the development of medical treatment 
of anorectic diseases, such as cancer cachexia. 
* Based on the findings of the meal and drinking patterns, it is concluded that timing 
is critical for the detected outcome at different phases of dioxin toxicity. Thus, to 
elucidate dioxin-targeted, site-specific pathways in the brain and in the periphery, 
further dose-and time-response studies will be of importance.  
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